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General introduction and aims of the thesis 
 
In this thesis, several studies are presented which were performed to 
obtain a better understanding of cardiovascular pressure-volume 
relations in dialysis patients. These pressure-volume relations are in 
many aspects different from those in patients without end-stage renal 
failure. In most dialysis patients, reduced or absent urine production 
leads to volume retention. Combined with factors such as anemia and 
the presence of an arteriovenous fistula, this leads to chronic volume 
overload.  During hemodialysis (HD), volume withdrawal by 
ultrafiltration may lead to intravascular hypovolemia and a low blood 
pressure. While left ventricular (LV) function in dialysis patients plays 
an important role in the hemodynamic defense, cardiac pathology is 
prevalent in the dialysis population. Renal insufficiency contributes to 
cardiac pathology in several ways. The most important cardiac 
complication is left ventricular hypertrophy (LVH). Pathogenetic 
factors for LVH are chronic volume overload and chronic pressure 
overload, which results from increased arterial stiffness. LVH may 
lead to LV dysfunction, which may eventually become manifest as 
heart failure. However, in dialysis patients, elevated cardiac filling 
pressures may reflect volume overload before HD rather than heart 
failure, and loading conditions are altered by volume witdrawal 
during HD. These cyclic changes in volume status hamper the 
assessment of LV function and the diagnosis of heart failure in 
dialysis patients.  
 
In Chapter 2, a review is presented of circulatory physiology during 
HD, cardiac pathology in renal failure, and current LV systolic and 
diastolic function measurements in clinical practice.  
 
Chronic pressure and volume overload may lead to a reduced 
myocardial perfusion pressure and chronic myocardial damage, 
especially in patients with LVH or myocardial fibrosis. Cardiac 
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troponin T (cTnT), a specific marker of myocardial injury, is often 
elevated in dialysis patients without evidence of acute ischemic 
myocardial injury due to coronary artery disease. In Chapter 3, the 
prognostic value of a random predialysis cTnT level in dialysis 
patients without clinical symptoms of acute coronary syndrome is 
analyzed. To determine the relationship between cTnT levels and 
cardiovascular disease, the predialysis cTnT levels in dialysis patients 
with a history of cardiovascular disease are compared to levels in 
dialysis patients with no such history. Serial measurements of cTnT 
and other markers of myocardial damage in the course of a HD 
session are analyzed to test whether there is an effect of the HD 
process itself. Finally, serial measurements of cTnT in patients 
admitted with a clinically manifest acute coronary event are also 
presented, to assess the diagnostic value of cTnT for acute myocardial 
injury in dialysis patients. 
 
LV diastolic dysfunction is believed to be common in dialysis patients, 
especially in patients with LVH. However, as conventional echo 
Doppler parameters are load-dependent, predialysis volume overload 
may lead to pseudonormalization due to increased cardiac filling 
pressures, and thereby mask diastolic dysfunction. In Chapter 4, we 
measure LV diastolic function before and after HD with the use of 
new Doppler applications, which have been advocated as preload-
independent.  
 
HD may impair cardiac relaxation by increasing the serum ionized 
calcium concentration, and thereby worsen LV diastolic function. In 
Chapter 5, we test the effect of HD without ultrafiltration on 
parameters of LV diastolic function.  
 
Chronic pressure overload resulting from a reduced aortic compliance 
signifies an increased cardiac pulsatile load, which promotes the 
development of LVH. In Chapter 6, we describe a pulse pressure 
Chapter 1 
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method based on the Windkessel model, which can be used to 
estimate aortic compliance non-invasively. This technique, which has 
not been applied before in a dialysis population, was used to test 
whether a reduction in volume overload by ultrafiltration during HD 
leads to an improvement in aortic pressure-volume relations.  
 
Commonly used parameters of LV systolic function, such as LV 
ejection fraction, are load-dependent. Measurement of LV pressure-
volume relations yields valuable information on how the LV is coupled 
to the vascular system. The end-systolic pressure-volume relationship 
or end-systolic elastance (Ees), an inherent characteristic of a given 
LV, is a parameter of LV systolic function which is almost insensitive 
to changes in load. In Chapter 7, we describe the acute LV response to 
preload reduction by nitroglycerine. These measurements were used 
to assess Ees non-invasively in order to compare LV systolic function 
in hypotension-prone and hypotension-resistant dialysis patients, 
independent of their volume status.  
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2.1  Circulatory responses to dialysis-induced hypovolemia 
 
2.1.1 Intradialytic hypotension 
Intradialytic hypotension, or dialysis-related hypotension, is a low 
blood pressure (BP) occurring during a hemodialysis (HD) session, as 
opposed to chronic persistent hypotension in which there is a 
continuously low BP between HD sessions [1–3]. To define 
hypotension in this setting, a decline in either mean arterial pressure 
(MAP) or systolic blood pressure (SBP) is used, which is expressed as 
percentual change from predialytic BP or as absolute pressure. A 
common definition is a decrease in SBP of ≥ 25% or SBP below 100 
mmHg, combined with symptoms of hypotension such as dizziness 
and nausea [4,5]. Intradialytic hypotension is a major and disabling 
complication of HD. It is severely distressing to the patient, usually 
requires nursing intervention and it limits the efficacy of HD as renal 
function replacement therapy [6].  
The incidence of intradialytic hypotension is usually reported as 
approximately 25% of all HD sessions [7–9] with a range of 15-50% 
[6,10,11]. The incidence may rise with an increasing age of the 
dialysis population. For comparison in studies, HD patients with a 
higher incidence of hypotension are called “hypotension-prone”, the 
rest of the patients being “hypotension-resistant”. To qualify a patient 
as hypotension-prone, the incidence is usually taken as hypotension 
in more than one third of all HD sessions during a three months 
period [12]. 
During intradialytic hypotension, two patterns in hemodynamic 
responses have been recognized, although often no clear distinction 
can be made, and transitional forms exist [13]. One pattern is a 
gradual BP decrease with tachycardia or only a slight increase in 
heart rate (HR). The other pattern is an acute drop in BP with 
bradycardia [14]. Bradycardic hypotension is less common than 
tachycardic hypotension [15], and is characterized by the Bezold-
Jarisch reflex, with acute sympathetic inhibition leading to 
 Left Ventricular Function in Hemodialysis  
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widespread vasodilatation, and concomitant parasympathetic 
activation leading to bradycardia [16].  
Many factors are involved in the pathogenesis of intradialytic 
hypotension. Although their relative contributions are not known, it is 
clear that the most important initiating factor is the decrease in blood 
volume, which is inherent to the HD procedure. During conventional 
HD with UF, volume is withdrawn from the hemodynamically active 
“central” circulation. Plasma is “refilled” from the interstitial 
compartment, where most of the volume overload resides. However, 
when UF rate exceeds plasma-refilling rate, intravascular hypovolemia 
is induced although the patient is still in a volume-overloaded state. 
Hypovolemia induces a state of sympathetic activation, irrespective of 
the type of hypotension that may follow. This makes a HD session 
with UF a circulatory stress test. The incidence of intradialytic 
hypotension in an individual could therefore be viewed as an 
indication of the effectiveness of the overall hemodynamic defense 
capacity of that dialysis patient. 
 
2.1.2 Hemodynamic defense mechanisms in hypovolemia 
In acute hypovolemia, the aim of the normal hemodynamic defense is 
to maintain BP in order to ensure perfusion of critical organ systems. 
To achieve this, the body must redistribute the remaining blood 
volume. The venous system contains an important buffer of pooled 
blood [17]. During the initial phase of volume withdrawal, venous 
constriction helps maintain an adequate venous return for cardiac 
filling. Arterial vasoconstriction not only increases systemic peripheral 
resistance (SVR), but, because of its selectivity, also helps redistribute 
the cardiac output (CO) among various vascular beds. While perfusion 
of non-vital organ systems gradually decreases, a more moderate 
constriction of the “central” circulation results in mobilization of the 
available blood into a smaller effective volume. 
This hemodynamic defense critically depends on sympathetic 
excitation and an increase in vasoactive hormones, such as 
Chapter 2 
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catecholamines, angiotensin, and vasopressin [17]. As volume 
withdrawal continues and CO starts to fall, an imminent decrease in 
BP changes the activity of cardiopulmonary, aortic arch and carotid 
receptors, which results in sympathetic excitation [6]. An increasing 
SVR with vasoconstriction of cutaneous, skeletal muscle and 
splanchnic arterioles counterbalances the decreasing CO to postpone 
hypotension. The time of onset and pattern of hypotension may be 
codetermined by additional factors which can affect the overall 
hemodynamic compensation capacity. These include the presence and 
severity of autonomic dysfunction, dialysate temperature and body 
temperature, and the effect of intradialytic food intake. All these 
factors influence the degree and selectivity of arterial vasoconstriction. 
When the maximal capacity of the hemodynamic defense mechanisms 
has been exceeded, BP can no longer be maintained and intradialytic 
hypotension will develop.  
During severe hypovolemia, the cardiodepressor or Bezold-Jarisch 
reflex can be triggered. This seems to be an unpredictable response, 
with a higher risk for patients who start HD with a lower BP or who 
are dialyzed with a high UF rate [15]. This reflex is thought to be a 
protective response to allow more filling time during marked preload 
reduction, or to defend the heart from ischemia by reducing its 
workload [18]. Activation of myocardial mechanoreceptors results in 
vagal afferents inhibiting central cardiovascular centers, overruling 
baroreflex-mediated activation.  
By contrast, tachycardic hypotension seems to be characterized by a 
gradual overwhelming of the patient’s maximal hemodynamic defense 
capacity due to the ongoing volume withdrawal. We hypothesized, 
that failure of the heart to respond to the ongoing sympathetic 
excitation with a sufficient increase in CO might eventually result in 
sympathetic exhaustion. This point in time would be reached earlier 
in patients with diminished myocardial responsiveness or contractile 
reserve, who are therefore hypotension-prone [5]. Conversely, one 
could also hypothesize that forward failure might develop as a result 
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of cardiac exhaustion due to the persistent constriction of the 
circulation, with an insufficiently preloaded heart pumping against a 
maximally increased afterload.  
 
2.1.3 Loading conditions and left ventricular function  
The circulation is a closed-loop system, and the interaction between 
the heart and the vascular system is reflected in terms of loading 
conditions. Preload is the end-diastolic LV pressure (or volume). This 
is the distending force of the ventricular wall, which is directly related 
to myocardial sarcomere length just before the start of contraction, 
and therefore refers to the resting tension of the muscle. The actual 
level of the preload depends not only on the diastolic myocardial 
properties, but also on the effective blood volume and the venoatrial 
system properties [19]. Afterload can be defined as arterial input 
impedance, and is related to the myocardial muscle tension during 
the shortening phase of contraction. The actual level of the afterload 
depends not only on the systolic myocardial properties (contractile 
state), but also on the effective blood volume and the arterial system 
properties, which consist of SVR, arterial compliance, and the inertia 
of blood [19]. In contrast to SVR, compliance and inertia introduce a 
hindrance to flow that depends on the frequency components, and 
thus on HR.  
The goal of LV systolic function is to eject a physiologically adequate 
volume of blood into the aorta. This depends on the complex 
interaction between contractility and afterload. Sympathetic 
stimulation increases stroke volume (SV) not only by increasing 
contractility and reducing end-systolic volume (ESV), but also by 
increasing diastolic filling time and end-diastolic volume (EDV), and 
thereby increasing preload of the muscle fibers (preload recruitment). 
Without increased contractility or preload, an increased HR would 
result in a decrease in SV due to insufficient cardiac filling time, and 
might even adversely affect CO. Therefore, sympathetic stimulation 
Chapter 2 
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improves cardiac pump function by stimulating the two key functions 
of the LV: contractility and preload recruitment.  
LV diastolic function is the ability to provide a physiologically 
adequate preload, resulting in sufficient sarcomere length necessary 
for the next contraction. Diastole can be divided into an isovolumic 
relaxation phase followed by a filling phase, which is subdivided into 
an early filling phase and late filling due to atrial contraction. LV 
diastolic function results from both an active relaxation process and 
the passive elastic properties which determine LV compliance. In an 
LV with low compliance, small changes in LV diastolic volume will 
result in large changes in LV diastolic pressure. Consequently, a less 
compliant LV is more vulnerable to reductions in venous return, as it 
requires higher filling pressures. Although diastolic abnormalities are 
believed to precede systolic abnormalities as assessed by conventional 
echocardiographic measurements, coexistence of systolic and diastolic 
dysfunction in a spectrum of different severity is common [20]. 
To summarize, the loading conditions of the circulation reflect the 
combined effect of intrinsic myocardial properties, vascular 
properties, and the effective blood volume (Figure 1). Volume 
withdrawal during HD alters these loading conditions. Dialysis-
induced hypovolemia with a reduction in cardiac filling may 
eventually lead to a decrease in CO and a compensatory increase in 
SVR resulting from sympathetic stimulation. When the maximal 
capacity of the hemodynamic defense mechanisms has been 
exceeded, hypotension ensues. Impairment of LV systolic and diastolic 
function makes the heart more vulnerable to changes in loading 
conditions. 
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Figure 1: The loading conditions of the circulation reflect the combined effect of 
intrinsic myocardial properties, vascular properties, and the effective 
blood volume. 
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ANS: autonomic nervous system; RAAS: renin-angiotensin-aldosterone 
system; LV: left ventricular; SVR: systemic vascular resistance 
 
 
 
2.2 Cardiac pathology in renal insufficiency 
 
2.2.1 Cardiovascular complications of progressive renal insufficiency 
Most of the consequences of renal insufficiency start well before the 
onset of HD. One of the first is secondary hyperparathyroidism. An 
elevated parathyroid hormone (PTH) has been related to the 
development of myocardial fibrosis [21]. As renal function declines 
further, without proper diet and medication phosphate levels may 
rise. Hyperphosphatemia per se had a significant effect on myocardial 
fibrosis in rats [22].  Hyperphosphatemia also directly affects 
parathyroid growth by increasing the expression of proliferating cell 
Chapter 2 
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nuclear antigens [23]. Elevated calcium – phosphate product 
predisposes to diffuse calcification, which can involve the heart and 
the arterial system, decreasing the elastic properties of both.  
Increased arterial stiffness due to arteriosclerosis impairs the 
cushioning function of the aorta and large arteries, and leads to 
systolic hypertension and chronic pressure overload, a risk factor for 
the development of left ventricular hypertrophy (LVH) [24]. A further 
decrease in renal function leads to decreased production of 
erythropoetin resulting in renal anemia. With less oxygen per volume 
of blood delivered to the tissues, CO needs to increase in chronic 
anemia, leading to volume overload, another pathogenic factor in the 
development of LVH [25]. As renal insufficiency progresses, the 
increased severity of uremia and metabolic acidosis may also 
adversely affect the circulation. Impairment of vasomotor reflexes, 
resulting from uremic autonomic neuropathy, leads to impaired 
ability to increase SVR during volume withdrawal. Uremia may also 
lead to loss of appetite. This may result in alimentary deficiencies for 
vitamins or iron, which may worsen anemia. The prevalence of 
hypertension is high in chronic renal insufficiency (87-90%) [26]. 
Arteriosclerosis, increased sympathetic tone from failing kidneys [27], 
and progressive salt and water retention can all contribute to an 
elevated systolic and /or diastolic BP. Reduced diuresis eventually 
leads to a state of chronic volume overload. 
If HD is chosen as a chronic renal replacement therapy, access to the 
circulation is usually obtained by an arteriovenous fistula. The 
creation of such a shunt has considerable repercussions for the 
circulation by decreasing total peripheral resistance, and demanding 
an increase in CO [28]. This adds to the existing volume overload. 
Finally, as a result of HD, there may be excessive removal and loss of 
homeostatic regulation of L-carnitine, which has a critical role in the 
process of cellular energy production [29]. Low L-carnitine levels are 
associated with LV dysfunction [30]. 
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To summarize, not only is cardiovascular disease a major cause of 
renal insufficiency, but renal insufficiency itself contributes to cardiac 
pathology in several ways. At least half of all patients starting dialysis 
therapy have overt cardiovascular disease [31]. Both the quantity and 
quality of the myocardial tissue may be affected in end-stage renal 
disease (ESRD) patients, due to the process of LV remodeling. 
 
 
Figure 2:  The increasing prevalence of left ventricular hypertrophy with 
progressive renal insufficiency, determined by calculated creatinine 
clearance, and the prevalence in patients starting dialysis (Reprinted 
from Levin A. Am J Kidney Dis 1999;34:125-134) 
 
 
 
 
 
2.2.2 Left ventricular remodeling in ESRD 
With progressive renal insufficiency, there is an increasing prevalence 
of LVH [32] (Figure 2). About 75% of ESRD patients have LVH [33,34], 
and it has been recognized as the most common cardiovascular 
alteration observed in ESRD [35]. Predictors of LVH include age, body 
mass index, and duration of hypertension [36]. LVH is usually 
diagnosed by echocardiography as an increased LV mass index 
(LVMI), indexed either by body surface area (g/m2) or by height (g/m). 
The use of the index by height appears to be more appropriate in 
dialysis patients, as factors such as malnutrition and volume 
Chapter 2 
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expansion tend to affect the estimation of body surface area in this 
population [37]. A variety in cut-off values and indexation methods 
makes the interpretation of LVH studies more difficult. Using the well-
established LV mass calculations from Penn convention 
measurements according to Devereux and Reichek, LVH is diagnosed 
as LVMI ≥ 134 g/m2 or ≥ 143 g/m for men, and ≥ 110 g/m2 or ≥ 102 
g/m for women [38–40]. Using the parameters LVMI by height and 
relative wall thickness (RWT = 2* wall thickness / end-diastolic 
diameter), four classes of LV geometry may be recognized: normal 
geometry (normal LVMI and normal RWT), concentric remodeling 
(normal LVMI and increased RWT), eccentric LVH (increased LVMI 
and normal RWT), and concentric LVH (increased LVMI and increased 
RWT) [41]. Concentric LVH, which allows generation of greater 
intraventricular pressure by a parallel growth of contractile proteins, 
is thought to be primarily associated with pressure overload (Figure 
3). Chronic volume overload is thought to lead to eccentric LVH with 
LV dilatation, which allows for an increased SV by a growth of 
contractile proteins in series. In view of the combined presence of 
pressure and volume overload, it is not surprising that, although both 
concentric and eccentric LVH are prevalent in the dialysis population, 
LVH in ESRD patients combines the features of both types [25,34]. In 
the Framingham study, a different cardiovascular risk was observed 
for these different classes of LV geometry in subjects without known 
cardiovascular disease [42]. Subjects with concentric LVH had the 
highest LVMI. They also had the worst prognosis: an odds ratio for 
incident cardiovascular disease compared to subjects with normal 
geometry of 1.3 for men and 1.2 for women. Paoletti et al. found 
eccentric LVH in dialysis patients to be less responsive to ACE 
inhibition and to be associated with a greater cardiovascular risk 
during a 3-year follow-up period than concentric LVH [43]. It is 
therefore thought that factors other than hemodynamics, such as  
 Left Ventricular Function in Hemodialysis  
 25
Figure 3: Pathogenesis of left ventricular hypertrophy with eccentric and 
concentric geometry (Reprinted from Grossman W. Am J Med 
1980;69:576-584) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
growth factors and signaling pathways, may codetermine the LV 
geometry. The progression rate of LVH in dialysis patients has been 
shown to be an independent prognosticator for cardiovascular events 
[44], whereas in patients who had a regression of LVH one year after 
the onset of HD, there was an improved cardiac outcome [45]. 
Correction of anemia was not found to lead to regression of LVH after 
one year, but appeared beneficial by preventing LV dilatation [46]. The 
combined treatment of anemia and hypertension did result in 
regression of LVH in some dialysis patients. In these patients, there 
was a concomitant favorable effect on cardiovascular and all-cause 
survival [47]. Regression of LVH was associated with the use of 
angiotensin-converting-enzyme inhibitors, possibly due to their 
antiproliferative and anti-inflammatory effects [48].  
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In LVH there are both abnormalities in active relaxation, resulting in 
increased diastolic myocardial wall tension, and in passive elastic 
properties with reduced ventricular compliance [34,49], indicating the 
presence of LV diastolic dysfunction. LV pressure-volume loops, 
obtained with invasive measurements in HD patients in resting 
conditions as well as during phenylephrine and dobutamine 
administration, have clearly shown the steep relationship between 
end-diastolic volume and pressure [50]. An increased LV mass has 
been found to be associated with an increased incidence of 
intradialytic hypotension [51,52]. However, for LV diastolic 
dysfunction to occur, LVH is not required [53].  
While LV remodeling due to hemodynamics and growth factors may 
lead to LVH, the myocardial tissue in patients with renal insufficiency 
can also change as a result of fibrosis. In patients with similar LVMI, 
uremic patients have more myocardial fibrosis than non-uremic 
patients [54]. Not only a chronically elevated PTH, but also 
angiotensin II, aldosterone, endothelin, and increased plasma 
catecholamines have been associated with the development of 
myocardial fibrosis. These hormones are involved either in blood 
pressure and volume control or in calcium homeostasis, which may 
well explain the increase in prevalence in uremic patients. 
LV remodeling may not only lead to decreased LV compliance, but 
also to a decreased myocardial capillary density. This may adversely 
affect myocardial perfusion, which may already be compromised since 
coronary artery disease is prevalent in the dialysis population. 
Impaired coronary perfusion can also lead to ischemic heart disease 
and a reduction in myocardial flow reserve [21,55]. This may become 
symptomatic as a result of the circulatory strains of predialytic 
hypervolemia and UF-induced intravascular hypovolemia during HD. 
Patients may present with an acute coronary syndrome, but also with 
symptoms of heart failure. 
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2.2.3 Heart failure and left ventricular dysfunction in ESRD 
The essential function of the heart as a pump is to provide an 
appropriate CO against a given afterload. Heart failure, whatever its 
cause, is characterized by a low CO, i.e. a lower output than that 
which is physiologically required, despite reduction in afterload. Heart 
failure is associated with but not equal to LV dysfunction [56]. Heart 
failure is present when LV function limits CO. LV dysfunction, either 
reduced contractility or impaired relaxation, may be compensated at 
rest, and may only become apparent in symptoms and signs of heart 
failure during exercise or a cardiovascular stress test such as the 
dialysis procedure. We previously showed hypotension-prone dialysis 
patients to have a diminished contractile reserve, i.e. lower increase in 
CO during dobutamine stress echocardiography, as compared to 
hypotension-resistant dialysis patients [5]. In concentric LV geometry, 
a condition prevalent in HD patients, cross-fiber shortening and 
thickening compensates for the decreased contractile efficiency of 
cardiomyocytes at the cost of a decreased LV contractile reserve (41). 
Therefore, reduced contractility or LV systolic dysfunction may lead to 
an inability to generate a sufficient CO during a hemodynamic 
challenge, and could contribute to an increased frequency of 
intradialytic hypotension [57,58]. However, studies in animals and 
humans have shown that in acute hypovolemia, cardiac 
compensation mechanisms resulting from sympathetic activation play 
a limited role. BP response was not altered under pharmacological ß-
adrenergic blockade or by cardiac denervation [17]. Optimizing pump 
function has hardly any effect if cardiac filling is decreased to the 
point that SV is too low for an adequate CO.  
From these studies it was concluded that, in acute hypovolemia, CO 
is determined by the amount of cardiac filling (preload), which is, of 
course, in line with the Frank-Starling mechanism. Thus, adequate 
cardiac filling is a prerequisite for maintaining CO, and impairment of 
filling will threaten CO at an earlier stage of hypovolemia. In the 
presence of LV diastolic dysfunction, adequate cardiac filling can only 
Chapter 2 
 28 
be achieved at high levels of left atrial filling pressure. As venous 
return is reduced during HD by UF, the presence of LV diastolic 
dysfunction could lead to forward failure. There are indications that 
impaired cardiac filling as assessed with Doppler echocardiography is 
common in HD patients, and that it has a role in intradialytic 
hypotension [59]. HD patients with an E/A ratio indicative of impaired 
early diastolic filling have been found to be hypotension-prone [60].  
A low CO may lead to forward failure, with a tendency to develop 
hypotension and diminished perfusion of organs, and to backward 
failure, with pulmonary congestion, peripheral edema and increased 
cardiac filling pressures. However, in dialysis patients, it is difficult to 
distinguish between congestive heart failure reflecting LV dysfunction 
or extracellular volume overload before dialysis [33]. In addition, 
during the dialysis procedure, cardiac filling pressures are directly 
altered by UF. Therefore, these cyclic changes in volume status 
hamper the assessment of LV function in dialysis patients. 
 
 
2.3 Left ventricular function assessment in dialysis patients 
 
2.3.1 Systolic function assessment 
Ideally, LV function should be assessed by simultaneous 
measurement of LV pressure and volume throughout the cardiac 
cycle. These invasive measurements can only take place under 
laboratory conditions [50]. For measurements in daily clinical 
practice, we have to rely on imaging techniques. These yield 
parameters that can only provide indirect information on actual 
physiologic processes. Of these techniques, echocardiography is the 
most important and commonly used diagnostic tool. Different 
parameters are used to assess LV systolic function. 
SV (ml) is the difference between LV end-systolic and end-diastolic 
volume: 
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SV = EDV – ESV 
 
LV volumes can be calculated from one-dimensional M-mode or from 
two-dimensional images, but conversion to the three-dimensional 
parameter volume leads to amplification of measurement 
inaccuracies. Furthermore, assumptions about the shape of the LV 
affect these SV measurements. A common way to measure SV from 
two-dimensional images is the Method of Discs, in which multiple 
equally spaced diameters along the LV cavity are converted to a disk 
area measurement (Simpson’s rule). Addition of the disk segments 
yields LV volume. Delineating the LV cavity by tracing of the 
endocardium can be done manually or by means of automated border 
detection.  
SV can also be assessed from Doppler blood flow measurements in 
the LV outflow tract. In the absence of significant valvular 
regurgitation, SV equals aortic ejection volume. This is the product of 
the LV outflow tract area (A) and the Doppler mean flow velocity (V) – 
ejection time (T) integral. A is calculated as πr2, in which r is the 
radius of the aortic annulus. 
 
SV (cm3 or ml) = A (cm2) . V (cm.s-1) . T (s) 
 
SV can be expressed in absolute volume units (ml), but also as 
volume fraction of the EDV. This is the LV ejection fraction (EF), 
which is the most commonly used echocardiographic parameter of LV 
systolic function. 
 
EF = [(EDV-ESV) / EDV] *100%. 
 
LV systolic dysfunction is usually defined as an (EF) <50% [56]. 
In reporting the echocardiographic assessment of the LV contraction 
pattern, an alternative approach is to report the myocardial fractional 
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shortening (FS), which is the difference between end-diastolic 
diameter (EDD) and end-systolic diameter (ESD) relative to EDD:  
 
FS = [(EDD-ESD) / EDD] *100% 
 
Normal FS is > 28% [61]. This parameter describes the contraction 
pattern in one dimension in a certain LV segment. However, to be 
useful, FS at endocardial level can only provide information on overall 
LV systolic function if the LV has a normal shape and uniform 
function. Midwall FS has been proposed as a less geometry-dependent 
measurement of contraction [62]. 
 
 
2.3.2 Diastolic function assessment 
As with LV systolic function assessment, accurate measurement of LV 
diastolic function requires simultaneous LV pressure and volume 
measurements. In a recent study, invasive measurements of LV 
diastolic function in non-uremic patients with diastolic heart failure 
(diagnosed as signs and symptoms of heart failure and a normal EF) 
showed the presence of significant abnormalities in active relaxation 
and passive stiffness [53].  
In daily clinical practice, however, pulsed Doppler transmitral flow 
velocity measurements are generally used to assess LV diastolic 
function. A decreased peak early transmitral flow velocity (E) due to 
impaired diastolic filling with an increased contribution of atrial 
contraction (A) results in a decreased E/A ratio (<1), the so-called 
“impaired relaxation”, which is considered diagnostic of diastolic 
dysfunction. It is one of four distinct E/A ratio patterns, which form a 
grading system representing a continuum from normal to severe 
diastolic dysfunction (Figure 4). While the E/A ratio is >1 with normal 
diastolic function, decreased early filling in diastolic dysfunction 
results in a pattern of delayed relaxation with E/A <1. Progression of 
diastolic dysfunction leads to pseudonormalization, in which the  
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Figure 4: Doppler patterns of early (E) and atrial (A) transmitral flow velocity 
form a grading system representing a continuum from normal to 
severe diastolic dysfunction (Reprinted from Aurigemma GP, Gaasch 
WH. N Engl J Med 2004;351:1097-1105) 
 
 
 
 
increase in left atrial pressure leads to a “normal” E/A ratio >1.  The 
impairment in LV relaxation can also become manifest as an increase 
in E deceleration time and isovolumic relaxation time. Finally, severe 
diastolic dysfunction results in a restrictive pattern with E/A >2, in 
which the stiff ventricle with an initially low intraventricular pressure 
allows abnormally increased early filling velocity, but very little 
subsequent filling due to a rapid increase in intraventricular pressure. 
Newer Doppler applications include Doppler Tissue Imaging (DTI) and 
color M-mode Doppler (Figure 5). With the use of DTI, mitral annulus 
peak tissue velocities can be assessed during early diastole (e) and 
atrial contraction (a), which depend on LV relaxation and compliance. 
With increasing age, normal values for e decrease and for a increase, 
indicating a decrease in diastolic properties with a compensatory 
increase in atrial contraction from middle age. Normal values have  
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Figure 5: Peak early (E) and atrial (A) transmitral Doppler velocities and 
deceleration time (DT) of early transmitral flow velocity. Using Doppler 
tissue imaging (DTI), two distinct signals which are directed away 
from the LV centroid, are obtained during early (e) and late (a) 
diastole. Flow propagation velocity (Vp) is measured from color M-
mode recordings as the slope of the first aliasing velocity during early 
filling from the mitral valve plane into the LV cavity (Reprinted from Ie 
EH, et al. J Am Soc Nephrol 2003;14:1858-1862) 
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been reported as e >10 cm/s in younger subjects and e >8 cm/s in 
older subjects, and diastolic dysfunction has been defined as e <8 
cm/s [63,64]. With the use of color M-mode Doppler, the diastolic flow 
propagation velocity (Vp) from the mitral orifice to the apex cordis over 
time is assessed, also a parameter of LV diastolic function. Diastolic 
dysfunction has been defined as Vp <45 cm/s [63]. A recent study 
compared both parameters and found e to be a more sensitive 
parameter in the detection of mild to moderate diastolic dysfunction 
than Vp [65]. 
 
2.3.3 Load dependence of left ventricular function parameters 
The success of EF as a measure of LV systolic function in clinical 
conditions is probably derived from the observation that, when LV 
contractility is reduced, SV is maintained at an increased EDV, 
leading to a reduced EF. However, the preloaded ventricular pump 
needs to eject against a given afterload, so determination of SV or EF 
does not characterize pump function alone. Interpretation of these 
parameters as measures of LV systolic function is only meaningful 
with concomitant information on LV volumes and afterload [56,66]. 
This information is often not provided or taken into account. 
Parameters such as EF and SV, which describe the entire 
cardiovascular system rather than the intrinsic properties of the 
myocardium, are affected by changes in loading conditions, and are 
therefore called “load-dependent” [67–69]. 
The influence of load is particularly important when evaluating LV 
function in HD patients [70]. In these patients, UF leads to rapid 
changes in volume status resulting in substantial changes in preload 
and afterload. This affects LV function measurements, but the relative 
contribution of the changing loading conditions to a change in LV 
function parameters is difficult to determine. A lower EF after HD 
cannot discriminate between decreased preload, increased afterload, 
or decreased contractility, because of its load dependence. A 
decreased EDV due to a reduction in venous return may increase EF. 
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An increased SVR due to adrenergically-induced vasoconstriction may 
decrease EF. The opposing effects of a reduction in EDV (preload) and 
an increase in SVR (afterload) after HD may also result in an 
unchanged EF.  
The issue of load dependence is equally important in the assessment 
of LV diastolic function, as the effect of cardiac filling pressure is part 
of the grading system of LV diastolic dysfunction mentioned before. 
Progressive increases in cardiac filling pressure correspond with 
increasingly severe diastolic dysfunction, which may eventually lead 
to a clinical picture of congestive heart failure with cardiogenic 
volume retention. In dialysis patients however, volume retention due 
to anuria and volume removal by UF lead to changes in loading 
conditions independent of LV function. The preload dependence of 
pulsed Doppler transmitral flow measurement is an important 
confounding factor [71]. This was clearly shown by Choong et al [72], 
who used Doppler echocardiography together with invasive 
hemodynamic measurements and decreased preload by infusing 
nitroglycerine in patients undergoing cardiac catheterization for the 
evaluation of chest pain. Nitroglycerine causes systemic 
venodilatation, and accordingly, decreases in right atrial, mean 
pulmonary capillary wedge, LV end-diastolic, and mean aortic 
pressures were measured. During infusion of nitroglycerine, 
decreased cardiac filling pressures induced changes in Doppler 
transmitral flow velocity profile which resemble those commonly taken 
as proof of LV diastolic dysfunction.  
The preload dependence of these measurements hampers the 
assessment of LV diastolic function in dialysis patients. Predialysis 
volume overload increases peak early filling velocities and preload, 
and could mask impairment of early diastolic filling [73]. Conversely, 
intravascular hypovolemia resulting from UF during dialysis may 
reduce preload, which could mimic a pattern of LV diastolic 
dysfunction [50,72].  Sequential Doppler measurements during 
dialysis showed that early filling progressively declined in 
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hypotension-prone HD patients, to the point that just prior to the 
onset of hypotension diastolic filling was almost entirely the result of 
atrial contraction [35,74]. Left atrial pressure also affects Doppler 
pulmonary vein flow. Diastolic forward flow velocity has been shown 
to reflect both LV diastolic function and preload [75]. Therefore, it is 
crucial to correct for the effect of preload when evaluating LV diastolic 
function by means of these Doppler flow velocity measurements.  
In view of the high prevalence of cardiac pathology such as LVH and 
myocardial fibrosis, it seems fair to assume that reduced contractility 
and impaired relaxation are prevalent in the dialysis population. 
However, because LV systolic and diastolic function assessment in the 
dialysis population is hampered by the load dependence of 
echocardiographic parameters, the actual prevalence of LV 
dysfunction is unknown. 
 
2.3.4 Load-independent left ventricular function assessment in clinical 
practice; quest for the Holy Grail 
As many of the detrimental effects of renal insufficiency on LV 
function start well before the onset of HD, LV function assessment 
should be started before the patient reaches ESRD. This has 
advantages for both diagnosis and secondary prevention of LV 
dysfunction. In the absence of clinically significant volume overload 
characteristic of ESRD, LV function assessment in patients with 
moderate renal insufficiency can be performed with the use of Doppler 
parameters. However, in view of the demonstrated load dependence of 
these commonly used LV systolic and diastolic function parameters, it 
is important that when measurements of LV function are reported in 
HD patients, both the time relation to the dialysis process and the 
volume status should be specified. Assessment of LV function should 
not be performed shortly before HD, but preferably in a relatively 
normovolemic state, at least one hour after HD. 
The newer Doppler parameters of LV diastolic function, DTI and color 
M-mode, have been reported to be less load-dependent [76–80]. These  
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Figure 6: Change in peak transmitral flow velocities (E and A), peak mitral 
annulus velocities (e and a) and flow propagation velocity (Vp) 
following hemodialysis. (Reprinted from Ie EH, et al. J Am Soc 
Nephrol 2003;14:1858-1862) 
 
 
 
 
techniques could therefore have a potential benefit in the assessment 
of LV diastolic function in hemodialysis patients. Using these 
techniques, we demonstrated LV diastolic dysfunction in a group of 
dialysis patients [81]. Unexpectedly, we found these relatively 
“preload-independent” echo Doppler parameters to exhibit a pattern of 
preload dependence similar to that displayed by the conventional 
Doppler flow velocity measurements (Figure 6). This was recently 
confirmed for mitral annulus velocity by DTI in a larger cohort [82]. 
Similarly, the systolic mitral annulus wave by DTI was shown to 
depend on changes in load [83]. A further refinement of DTI, color 
tissue velocity imaging (TVI), which has also been claimed as less 
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load-dependent, allows for a more general assessment of LV wall 
mean velocities during both systole and diastole [84]. Using this 
technique, Hayashi et al [69] found lower peak systolic velocities and 
e diastolic velocities in dialysis patients before HD as compared to 
sex- and age-matched controls. Mean e by TVI before HD was 
indicative of diastolic dysfunction, and was unchanged after HD. By 
contrast, peak systolic velocity increased significantly, which could be 
explained by a decreased afterload in some but not all patients.  
The aim of measuring LV function more accurately seems to be a 
trade-off between obtaining accurate physiologic insight and practical 
value for the daily clinical routine. In addition to two-dimensional 
echocardiography, there are other imaging techniques including 
bioimpedance cardiography, magnetic resonance imaging (MRI), and 
three-dimensional echocardiography. Bioimpedance cardiography is a 
relatively new technique, which measures volumes non-invasively 
based on changes in body impedance that result from the changes in 
intrathoracic blood flow during the cardiac cycle [85]. The HD 
procedure, however, not only changes volume status but also solute 
concentrations, which affects bioimpedance. The fluctuation in 
bioimpedance variables complicates the interpretation of these 
measurements, although measurements in a dryweight state appear 
to be reproducible [86]. MRI is a more complicated technique which 
may trade better imaging for practical value [87]. Three-dimensional 
echocardiography may hold a promise for the future [88]. However, 
even with improved accuracy of LV volume assessment, all imaging 
techniques still provide indirect information only, lacking LV pressure 
measurement. The measured volumes are subject to the impedance 
properties of both the heart and the venoarterial system, and as such 
inherently load-dependent.  
Ultimately, the aim is to combine these LV volume measurements 
with simultaneous information on LV pressure in clinical practice. 
This can be used to establish the LV pressure-volume relationships or 
elastance E (∆P/∆V) throughout the cardiac cycle to measure the  
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Figure 7:  Pressure-volume loop of the left ventricle for a single cardiac cycle 
  (A to F). (Reprinted from Berne RM, Levy MN: Principles of   
  physiology. 3rd ed. Mosby, Inc. St. Louis, MO, 2000, p 210) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
changes in myocardial contractility [89] (Figure 7). The end-systolic 
pressure-volume relationship represents the mechanical properties of 
a fully contracted ventricle. End-systolic elastance (Ees) is an inherent 
characteristic of a given LV, and is a parameter of LV systolic 
functionwhich is almost insensitive to changes in preload and 
afterload [90]. In a pressure-volume diagram showing pressure- 
volume measurements of consecutive cardiac cycles during a change 
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Figure 8:  Pressure-volume loop diagram of left ventricular (LV) contraction: 
normal situation and reduced end-systolic elastance (Ees) in LV 
systolic dysfunction. 
 
 
 
 
 
 
 
in preload, the end-systolic pressure-volume relationship is linear and 
thus represented by a straight line [89]. The slope of this line 
represents Ees (Figure 8). A decreasing Ees value within the same 
patient over time, therefore, indicates deterioration of LV systolic 
function. The invasive character of intraventricular pressure and 
volume measurements and the need for load alterations has limited 
clinical application of Ees. To measure Ees as a clinically applicable 
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method, one has to rely on non-invasive simultaneous measurements 
of LV pressure and volume [91]. 
LV volume changes can be measured with an imaging technique as 
described above. Although three-dimensional echocardiography may 
become a valuable technique for the accurate assessment of small 
changes in LV volume, it is not possible to obtain a beat-to-beat 
recording of LV volumes with this technique as yet.  
The LV pressures can only be measured with the use of an 
intraventricular catheter. However, an estimate of changes in LV end-
systolic pressure can be obtained by non-invasive measurements of 
BP. Model flow analysis allows for the computation of aortic pressures 
from peripheral blood pressures [92]. Changes in peripheral peak 
pressure, measured invasively in the femoral and brachial artery or as 
SBP by sphygmomanometry, have been shown to correlate with 
changes in LV end-systolic pressure, provided that there is no aortic 
stenosis or any other LV outflow tract obstruction present [93]. 
Cardiac filling pressures might be estimated non-invasively by 
measuring the ratio of a preload-dependent parameter to a preload-
independent parameter. E/e and E/Vp have been used to this end 
[78,79]. However, as neither mitral annulus velocity by DTI nor Vp by 
color M-mode is a truly load-independent parameter, it seems 
doubtful whether these estimates provide accurate information on 
filling pressures in dialysis patients. 
Although Ees is a more accurate measure of LV systolic function, it is 
not fully load-independent, as studies have revealed the end-systolic 
pressure-volume relationship not to be exactly linear. Non-linearity is 
an even greater issue in the end-diastolic pressure-volume 
relationship, as can be clearly seen from Figure 7. An additional 
problem for non-invasive measurements of LV diastolic function is 
that in diastole, when the aortic valves are closed, peripheral 
pressures cannot be used as surrogate measure of LV pressures. 
Therefore, whereas more accurate LV systolic function assessment 
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may be within reach, the clinically applicable, non-invasive, 
measurement of end-diastolic LV pressure remains a challenge. 
If LV contractility were known after determination of Ees, one could 
obtain valuable information on how the LV is coupled to the vascular 
system. With this knowledge, HD patients with LV dysfunction could 
be identified more accurately. HD patients with heart failure could be 
distinguished from HD patients with excessive volume overload before 
HD, in whom lowering dry weight might suffice. Identification of HD 
patients with LV dysfunction at an earlier stage, i.e. before heart 
failure becomes clinically manifest, would not only help secondary 
prevention, but also provide a tool for measuring the results of 
treatment. In patients who already have LV dysfunction, the 
importance of reducing factors known to contribute to chronic 
pressure and volume overload, becomes even more obvious than in 
the general HD population. This includes adhering to a stringent 
sodium restriction, treating systolic hypertension, anemia and 
secondary hyperparathyroidism, and keeping urea and the calcium 
phosphate product low. Some drugs used in heart failure treatment in 
non-uremic patients are clearly less relevant or may have less 
predictable effects in HD patient, e.g. loop diuretics, load-altering 
medication such as nitrates, or beta blockers. However, angiotensin-
converting-enzyme inhibitors or angiotensin II receptor blockers could 
be initiated, and improvement in contractility could be monitored by 
measuring Ees. Accurate information on LV contractility would provide 
an important monitoring tool for intervention trials to guide new 
strategies in the treatment of LV dysfunction. If LV dysfunction 
persists, patients could benefit from slower UF rates, at the cost of an 
increase in total HD time. A switch to peritoneal dialysis or, in 
selected patients, nocturnal HD may then turn out to be valuable 
alternatives. So, although clinically applicable load-independent 
measurement of LV function seems as yet to remain a Holy Grail, the 
potential gain in improvement of quality of life and management of 
our HD patients is such that it is a valuable goal to pursue. 
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Abstract 
Cardiac troponin T (cTnT) is often elevated in hemodialysis (HD) 
patients without acute coronary syndrome (ACS). The aim was to 
assess the predictive value for mortality of predialysis cTnT in 
asymptomatic patients. If patients became symptomatic during follow-
up, cTnT was followed to assess its diagnostic value for ACS. 
Forty-nine asymptomatic HD patients were included, 30 patients with 
history of cardiovascular disease (CV+) and 19 without (CV-). In 11 
patients cTnT, myoglobin and creatine kinase (CK) were measured 
before and during HD. During ACS, cTnT was followed until recovery. 
A cTnT ≥ 0.03 µg/L was considered elevated. Follow-up was 2 years. 
cTnT was elevated in 82% (40/49). More CV+ patients had an elevated 
cTnT (28/30) than CV- patients (12/19; p=0.02). There was no change 
in cTnT, myoglobin and CK during HD. During ACS, cTnT increased 
above baseline, and tended to return to baseline after recovery. 
Mortality was 33% (16/49). Patients with elevated cTnT had a higher 
mortality rate (16/40) than patients with negative cTnT (0/9; p=0.02). 
Elevated cTnT levels in asymptomatic HD patients are not caused by 
acute myocardial injury or by HD itself. They may be related to 
chronic myocardial damage and decreased clearance, and are of 
prognostic value. During ACS, however, a cTnT rise above the 
individual baseline is diagnostic of acute myocardial injury. 
 
Introduction 
There is a high prevalence of cardiovascular (CV) disease in the 
hemodialysis (HD) population. The mean age of the population is 
rising, HD patients have accelerated atherosclerotic disease compared 
to age-matched controls, and CV disease is the primary cause of renal 
insufficiency in a large proportion of patients. Cardiac troponin T 
(cTnT) is a specific marker of myocardial injury. However, HD patients 
often have elevated cTnT levels without evidence of acute ischemic 
myocardial injury due to coronary artery disease (CAD) [1,2]. Another 
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cardiac troponin, cTnI, is less frequently elevated in the HD 
population [1,3].  
Until recently, it was thought that the elevation of cTnT levels in HD 
patients might be due to uremic myopathy [4]. However, as the 
currently used third-generation assays have virtually no cross-
reactivity with troponin T originating in skeletal muscle [5,6], 
myopathy is an unlikely cause of elevated cTnT levels in HD patients. 
Several possible causes remain. Elevated cTnT baseline levels may 
reflect silent ischemia. This can be detected by dobutamine-atropine 
stress echocardiography as new wall motion abnormalities. We 
observed silent ischemia in 7 out of 22 HD patients (32%) [7]. 
Elevated cTnT levels may also reflect minor myocardial damage 
without clinically significant CAD. This could be due to myocardial 
strain as a result of volume overload, decreased arterial compliance, 
left ventricular hypertrophy (LVH) or myocardial fibrosis [2,4,8]. 
Decreased renal clearance of cTnT fragments is thought to contribute 
to the increase in cTnT levels in HD patients [9]. 
The aim of this study was to investigate the prognostic value of a 
random predialysis cTnT level measurement in HD patients without 
clinical symptoms of acute coronary syndrome for predicting all-cause 
mortality during a follow-up period of 2 years. We also compared cTnT 
levels in HD patients with a history of CV disease (CV+) to levels in 
HD patients with no such history (CV-) to determine the relationship 
between cTnT levels and CV disease. If patients were admitted with a 
clinically manifest acute coronary event, serial measurements of cTnT 
were done until recovery to assess the diagnostic value of cTnT for 
acute myocardial injury in HD patients. Finally, the elevation of cTnT 
levels could be an effect of the HD process itself, and could result 
from increased production or from hemoconcentration during HD 
[10,11]. To test this hypothesis, serial measurements of cTnT and 
other markers of myocardial damage were made in a subset of 
patients in the course of a HD session.  
 
Chapter 3 
 56 
Methods 
Study population 
Subjects had to be free of clinical symptoms of ischemic heart disease 
one month prior to inclusion. All forty-nine HD patients in one 
dialysis center were included.  Mean age was 57 (±16) years. The 
patients were dialyzed three times per week according to their 
standard dialysis prescription. All treatments used Fresenius 4008 
machines, biocompatible membranes (Hemophane or Polysulphone) 
and bicarbonate-buffered dialysate (Fresenius Medical Care SK-F213 
or SK-F113). Thirty patients had a history of CV disease (Table 1), 
including myocardial infarction (7 patients), CAD for which coronary 
artery bypass surgery and/or percutaneous transluminal coronary 
angioplasty (PTCA) (5), CAD treated with medication (8), significant 
(>1+) valvular disease (5), diabetic nephropathy (4), renal artery 
stenosis (4), and peripheral vessel disease (2). Several patients in this 
group had a combination of CV diagnoses. Of the eight patients with 
CAD treated with medication, three had suffered a myocardial 
infarction and had used antianginal medication since, and five had 
lesions on coronary angiography, for which PTCA was technically not 
feasible. The other 19 patients had no history of CV disease. All 
patients were followed for two years. Patients were censored when 
their renal replacement therapy was changed, i.e. after a successful 
renal transplantation or when they changed to peritoneal dialysis. All-
cause mortality was used as the clinical endpoint.  
 
Study Design  
Random blood samples for the measurement of serum cTnT 
concentrations were obtained directly before initiating the HD 
procedure in all included patients. Samples were centrifuged and 
analyzed immediately.  
In a subset of 11 patients, on a separate occasion, samples were 
taken before and during HD to determine the effect of the HD 
procedure itself. In these patients, cTnT was measured at time zero  
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Table 1: CV+ group 
 
Pts cTnT AGE MI CAD CAD VD DN OTHER 
 (µg/L) (years)  CABG/PTCA Rx    
         
1 NEG 59    +   
2 NEG 59   +    
3 0,03 29    +   
4 0,04 69  +     
5 0,04 46    +   
6 0,05 70 +      
7 0,05 74  +     
8 0,05 71 +      
9 0,05 51    +   
10 0,06 52   +    
11 0,06 78      RAS 
12 0,06 78      RAS,PVD 
13 0,06 34     +  
14 0,07 81 +      
15 0,08 34     + PVD 
16 0,09 41  +     
17 0,09 45   +    
18 0,09 60   +    
19 0,11 72 +  +    
20 0,13 59     +  
21 0,13 61 +  +    
22 0,14 80      RAS,CVA 
23 0,16 24    +   
24 0,16 65      RAS,CVA 
25 0,16 53 +      
26 0,20 66     +  
27 0,30 79  +     
28 0,38 61 +  +    
29 0,39 49  +     
30 0,59 60   +    
 
 
Pts: patients; MI: myocardial infarction; CAD: coronary artery disease; CABG: 
coronary artery bypass graft; PTCA: percutaneous transluminal coronary 
angioplasty; Rx: medication; VD: significant (>1+) valvular disease; DN: diabetic 
nephropathy; RAS: renal artery stenosis; PVD: peripheral vessel disease; CVA: 
cerebrovascular accident 
 
 
(i.e. at the start of HD), after one hour and after four hours. Myoglobin 
and creatine kinase (CK) were measured at the same intervals as 
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additional cardiac markers of myocardial injury. It is noteworthy, that 
in this subgroup of 11 patients two predialysis samples were 
measured: both as random sample and as part of the serial 
measurements during HD. 
 
Laboratory Measurements 
For determination of cTnT, the Elecsys 2010 immunoassay analyzer 
was used with a third-generation electrochemiluminescence 
immunoassay (ECLIA; Roche Diagnostics). This ECLIA shows a cross-
reactivity of 0.001% with skeletal muscle TnT for a concentration of 
2000 ng/ml. The lower detection limit is 0.01 µg/L. The functional 
sensitivity is 0.03 µg/L. This is the concentration which meets an 
interassay coefficient of variation (imprecision) of 10%, and should be 
used as a medical diagnostic guide [12]. A cTnT level ≥ 0.03 µg/L was 
therefore considered elevated and indicative of myocardial injury. 
Myoglobin was determined by ECLIA using the Elecsys 2010 
immunoassay analyzer (Roche Diagnostics). The between-run 
imprecision is 3.4% at 83 µg/L. Creatine kinase (CK) was determined 
by a photometric enzymatic assay with a between-run imprecision of 
1.7% at 220 U/L. Upper reference value in our institution is 199 U/L. 
The diagnosis of acute coronary syndrome was made according to 
recent guidelines, which use ischemic symptoms, ECG and delta cTnT 
as criteria, not CK [12]. 
 
Statistical analysis 
Fisher’s exact test was used to analyze the association between the 
history of CV disease and cTnT positivity. The correlation of cTnT with 
age and urea was tested using the Spearman rank correlation 
coefficient. Survival data were analyzed using Kaplan-Meier analysis 
in which cTnT negativity and cTnT positivity were compared by means 
of the log rank test. Serial measurements of cTnT, myoglobin and CK 
before and during HD were compared using Friedman’s non- 
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Table 2: Distribution of study population according to baseline predialysis 
cTnT levels and history of CV disease. Using Fisher’s exact test, there 
were significantly more (p=0.02) patients with an elevated cTnT in the 
CV+ group (*). 
 
 
 cTnT neg cTnT ↑  
CV - 7 12 19 
CV + 2 28* 30 
 9 40 49 
 
 
 
parametric analysis of variance with repeated measures. If significant, 
this was followed by a post hoc test using Dunn’s analysis. A p-value 
of less than 0.05 was considered to indicate statistical significance.  
 
Results 
Median cTnT was markedly above cut off level: 0.07 µg/L (range 0 to 
0.59 µg/L). We observed an elevated cTnT in 82% (40/49) of the 
patients. In the CV+ group we observed significantly more patients 
with an elevated cTnT (28/30) than in the CV- group (12/19; p=0.02) 
(Table 2). Median cTnT was 0.09 µg/L in the CV+ group and 0.07 
µg/L in the CV-group. The cTnT level did not correlate with age, and 
there was a marginal correlation with predialysis urea (r=0.3; p<0.05). 
During the two-year follow-up, there were 7 acute coronary events in 
5 patients (all in the CV+ group) who were admitted with an acute 
coronary syndrome. One of these patients was among the patients 
who died later. All had an elevated baseline cTnT level (median 0.10 
µg/L; range 0.05-0.30 µg/L), and there was a further rise in cTnT. 
The maximal value for cTnT was reached one day after the onset of  
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Table 3: cTnT levels (µg/L) at baseline, during admission for acute coronary 
syndrome and new baseline after recovery.  
 
Event Baseline Onset Max CK max EKG ACS CAG Ther. New BL 
1 0.30 0.27 0.34 219 = UAP 2VD stents 0.23 
2 0.05 0.21 2.73 300 ST ↓ N-STEMI nd Rx 0.11 
3 0.13 0.11 0.51 475 LVH N-STEMI nd Rx 0.11 
4 0.09 nd 2.51 123 LVH N-STEMI nd Rx 0.08 
5* 0.08 0.13 0.72 86 ST ↓ N-STEMI 3VD stents 0.13 
6 0.10 0.10 25.63 139 ST ↑ STEMI 2VD stents 0.40 
7** 0.40 0.57 1.01 241 ST ↓ N-STEMI nd Rx 0.07 
 
Max: maximal cTnT value; CK max: maximal CK value (U/L); LVH: LVH with 
secondary repolarization abnormalities; ACS: Acute Coronary Syndrome; CAG: 
coronary angiography; VD: coronary vessel disease; Ther: therapy; New BL: new 
baseline after recovery; nd: not done; * Same patient as event 4 with an interval of 
three months. ** Same patient as event 6 with an interval of five months.  
 
 
the symptoms (Table 3 and Figure 1). In one event, there was only a 
minor rise in cTnT, leading to the diagnosis of unstable angina 
pectoris (UAP). One event was an ST elevation myocardial infarction 
(STEMI). In the other events, the absence of ST elevation combined 
with the rise in cTnT led to the diagnosis of Non-STEMI. In three 
events, the maximal CK value was below the upper limit of normal, 
and would not have led to the diagnosis of acute myocardial infarction 
using the old criteria. Three patients underwent coronary 
angiography. In these patients, multiple coronary vessel disease was 
found, which was treated with angioplasty and stenting. The other 
two patients were treated with medication. The cTnT level tended to 
return toward baseline level after recovery.  
No patient was lost to follow-up. Eight patients underwent renal 
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Figure 1: cTnT during acute coronary events with maximal value reached on 
Day 1 after the onset of symptoms (Day 0). 
 
 
 
transplantation. One of these had primary non-function and remained 
on HD, the others became HD independent. Three patients changed to 
peritoneal dialysis. All-cause mortality was 33% (16/49), 11 in the 
CV+ group and 5 in the CV- group. Causes of death were heart failure  
(6 patients), sudden death (4), endocarditis (1), cardiac tamponade (1), 
superior vena cava syndrome (1), vascular bleeding (2) and respiratory 
failure (1). In the patients with an elevated cTnT we observed a 
significantly higher mortality (16/40) than in the patients with 
negative cTnT (0/9; p=0.02) (Figure 2).  
In the subset of patients with serial measurements, there was no 
significant change in cTnT, myoglobin and CK during the HD 
procedure (Figure 3). 
 
Discussion 
The results of our study demonstrate a high incidence of elevated 
cTnT in asymptomatic HD patients. There was an association between 
an elevated cTnT and a history of CV disease. Among patients with  
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Figure 2: Survival during a two-year follow-up period in 49 HD patients: 
comparison of 9 patients with negative cTnT levels and 40 patients 
with elevated cTnT levels. Cumulative survival was significantly 
different (p=0.02). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
elevated cTnT, including both CV+ and CV- patients, there was 
increased mortality during the two-year follow-up. In patients with an 
acute coronary syndrome, there was a rise in cTnT from baseline 
reaching a maximum one day after the onset of symptoms. On the day 
of random cTnT measurement, none of our patients had symptoms of 
ischemic myocardial injury and the HD procedures were uneventful in 
all patients. Therefore it seems that in HD patients the utility of a 
random predialysis cTnT level above the upper reference limit of 0.03 
µg/L for the diagnosis of acute myocardial injury is questionable. 
However, during the two-year follow-up, several patients with an 
already elevated baseline level were admitted with an acute coronary 
syndrome. In these patients, there was a further rise in cTnT during 
the acute coronary event, and a tendency to return to the individual 
cTnT neg 
cTnT ↑
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baseline level after recovery. Therefore, when an acute coronary 
syndrome is clinically suspected, a cTnT rise above the individual 
baseline level does have significance for the diagnosis of acute 
myocardial injury.  
The observed association in our study between an elevated cTnT and 
a history of CV disease confirms the findings in previous studies 
[13,14]. HD patients with a positive CV history had a significantly 
higher chance of having an elevated cTnT level. Since all patients were 
asymptomatic at baseline, the elevated cTnT may point toward 
subclinical cardiac disease.  
Among patients with elevated cTnT, including both CV+ and CV- 
patients, there was increased mortality during the two-year follow-up. 
Therefore it appears that an elevated baseline cTnT level is a predictor 
of all-cause mortality rather than a marker of acute myocardial injury 
in this population. This finding is in accordance with several previous 
studies, although in some of these studies a higher cut-off level for 
cTnT elevation was used [10,15-19]. Using either CV mortality or all-
cause mortality or both as the clinical endpoints, these studies 
demonstrated a prognostic significance of an elevated cTnT baseline 
level.  
The observation that in a large proportion of HD patients baseline 
cTnT levels are raised, has led some to suggest that, consequently, 
reference values should be adjusted for this population [11]. 
Decreased clearance has been implicated as the cause of elevated 
cTnT levels. Since the molecular weight of cTnT is 37 kD, it is unlikely 
that renal clearance has a significant role in the elimination of free 
intact cTnT from plasma [1]. However, it has recently been shown that 
cTnT is fragmented into smaller molecules. Decreased renal clearance 
of these cTnT fragments probably contributes to increased cTnT levels 
in patients with renal insufficiency [9].  
Elevated baseline levels may be secondary to the HD procedure itself, 
and result from increased release or hemoconcentration during HD.  
In the absence of cardiac symptoms, an elevated cTnT level may 
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Figure 3: Serial measurements of markers of myocardial injury during HD. No 
  significant changes in cTnT, myoglobin and CK were observed. 
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reflect repeated episodes of silent ischemia during the HD procedure. 
The half-life of cTnT is sufficiently long to have increased predialysis 
levels resulting from the previous HD procedure 48 hours before. 
However, we did not observe an effect of HD in our population, as 
there was no change in cTnT levels during HD. Therefore, increased 
production resulting from the HD procedure seems unlikely. In 
addition, elevated cTnT levels before HD cannot be explained by 
hemoconcentration, because almost all patients were in a state of 
volume overload. In previous studies, cTnT was measured directly 
before and after HD only, and various results were found, i.e. a 
postdialysis increase or no change at all [2,10,11].  
Since there was no increase in measured cTnT levels during the 
course of HD, it is more likely that the elevated cTnT levels are a 
reflection of chronic myocardial damage. Several factors contribute to 
the increased incidence of CV disease in end-stage renal failure. These 
include volume and pressure overload due to water and salt retention, 
anemia, arteriovenous fistula and increased arterial stiffness. All 
these factors lead to LVH. Both LVH and myocardial fibrosis, which 
are common in the HD population, can lead to a decreased myocardial 
capillary density and reduction in myocardial flow reserve [20,21]. 
There was a much higher incidence of elevated cTnT in the CV+ 
group. It is possible that in this group an already compromised heart 
suffers relatively more from the cyclic changes in volume status and 
recurring strains of the HD procedure itself. This may lead to chronic 
minor myocardial damage as reflected by the elevation of baseline 
cTnT.   
We conclude that elevated baseline cTnT levels in this group of HD 
patients, who had no clinical symptoms of an acute coronary 
syndrome, were not directly caused by acute myocardial injury or the 
HD procedure itself, but may have been related to chronic minor 
myocardial damage and decreased clearance of cTnT fragments. The 
increase in cTnT level in these HD patients was both related to a 
history of CV disease and an increased risk of all-cause mortality, and 
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is of prognostic value. In patients with clinical symptoms of an acute 
coronary syndrome, elevations above the individual baseline level do 
appear to have diagnostic significance for acute myocardial injury. 
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Abstract 
Left ventricular (LV) hypertrophy leads to diastolic dysfunction. 
Standard Doppler transmitral and pulmonary vein (PV) flow velocity 
measurements are preload-dependent. New techniques such as mitral 
annulus velocity by Doppler tissue imaging (DTI) and LV inflow 
propagation velocity measured from color M-mode have been 
proposed as relatively preload-independent measurements of diastolic 
function. We studied these parameters before and after hemodialysis 
(HD) with ultrafiltration (UF) to test their potential advantage for LV 
diastolic function assessment in HD patients. Ten patients (seven with 
LV hypertrophy) underwent Doppler echocardiography one hour 
before, one hour after and one day after HD. Early (E) and atrial (A) 
peak transmitral flow velocities, peak PV systolic (s) and diastolic (d) 
flow velocities, peak e and a mitral annulus velocities in DTI and early 
diastolic LV flow propagation velocity (Vp) were measured. In all 
patients the E/A ratio after HD (0.54; 0.37-1.02) was lower (p<0.01) 
than before HD (0.77; 0.60-1.34). E decreased (p<0.01) whereas A did 
not. PV s/d after HD (2.15; 1.08-3.90) was higher (p<0.01) than before 
HD (1.80; 1.25-2.68). Tissue e/a after HD (0.40; 0.26-0.96) was lower 
(p<0.01) than before HD (0.56; 0.40-1.05). Tissue e decreased (p<0.02) 
whereas a did not. Vp after HD (30 cm/s; 16-47 cm/s) was lower 
(p<0.01) than before HD (45 cm/s; 32-60 cm/s). Twenty-four hours 
after the initial measurements values for E/A (0.59; 0.37-1.23), PV 
s/d (1.85; 1.07-3.38), e/a (0.41; 0.27-1.06) and Vp (28 cm/s; 23-33 
cm/s) were similar as those taken one hour after HD. We conclude 
that even when using the newer Doppler techniques DTI and color M-
mode, pseudonormalization due to volume overload before HD 
resulted in underestimation of the degree of diastolic dysfunction. 
Therefore, the advantage of these techniques over conventional 
parameters for the assessment of LV diastolic function in HD patients 
is limited. Assessment of LV diastolic function should not be 
performed shortly before HD and its time relation to HD is essential. 
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Introduction 
Intradialytic hypotension is an important complication of 
hemodialysis (HD) and its pathogenesis is not completely understood. 
It frequently requires intervention, which limits the efficacy of HD. 
The incidence is 25% with a range of 15-50% [1-3] and increases with 
age. Hypotension results from a decreased product of stroke volume, 
heart rate and systemic vascular resistance. Compensatory 
mechanisms, such as tachycardia and arterial vasoconstriction, 
require adequate venous return. Ultrafiltration (UF) withdraws volume 
from the hemodynamically active “central” circulation, whereas most 
of the volume overload resides in the interstitial, and to a lesser 
extent, in the intracellular compartment. The venous system contains 
an important buffer against hypovolemia [2,4-6]. However, if plasma-
refilling rate lags behind UF rate, intravascular volume depletion may 
exceed the limit of the buffer capacity, and venous return falls. 
Maintaining adequate cardiac filling when venous pressure decreases, 
critically depends on the diastolic function of the left ventricle (LV). 
LV hypertrophy (LVH) is common in end-stage renal disease (ESRD) 
[7,8]. While LV systolic function remains normal [9,10], myocardial 
relaxation decreases due to a slower re-uptake of calcium by the 
sarcoplasmic reticulum leading to decreased LV filling [11]. 
Myocardial fibrosis, which is more prominent in ESRD than in non-
uremic patients with similar LV mass index (LVMI), results in a 
decreased compliance. Factors in the pathogenesis of myocardial 
fibrosis include angiotensin II, chronically elevated parathyroid 
hormone (PTH), endothelin, aldosterone and increased plasma 
catecholamines [11]. 
To assess LV diastolic function, pulsed Doppler transmitral and 
pulmonary vein (PV) flow velocities are used. These parameters are 
known to be preload-dependent [12,13]. This is a confounding factor 
in HD patients, in whom filling pressure changes independent of 
cardiac function, as the volume status is acutely altered by UF. 
Predialysis overhydration leads to a high preload, which may mask 
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impairment of early diastolic filling. Conversely, HD with UF reduces 
preload, resulting in decreased peak early filling velocities and a 
pattern of diastolic dysfunction. The effect of preload changes is 
crucial and must therefore be accounted for in the assessment of LV 
diastolic function in HD patients.  
New Doppler measurements have been proposed which are relatively 
preload-independent [14-19]. These could be particularly helpful in 
the diagnosis of diastolic dysfunction in HD patients. Doppler Tissue 
Imaging (DTI) assesses the LV myocardial tissue velocities during 
diastole. Color M-mode assesses the velocity of the diastolic flow 
propagation velocity (Vp) from the mitral orifice to the apex over time. 
The aim of the present study was to test the preload dependence of 
these new echo Doppler parameters in HD patients.  
 
Methods 
Patients 
Ten HD patients (5 men and 5 women, median age 54, range 38-80 
years) were included in this study. Median time on HD was 2.5 years 
(range 1-7 years). Eight patients had no history of cardiac disease. 
One patient had undergone coronary artery bypass graft surgery 
seven years before. One patient had a history of unstable angina 
pectoris treated successfully by percutaneous transluminal 
angioplasty with stent placement two years before. None of them had 
symptomatic ischemic heart disease, significant (>1+) valvular disease 
or congestive heart failure. The ethical review committee of our 
hospital approved the study and written informed consent was 
obtained from all patients. 
 
Hemodialysis 
All patients were dialyzed following a standard dialysis prescription, 
which had been unchanged for several weeks. Dryweight was 
considered optimal when patients remained without symptoms of 
dyspnea, orthopnea or edema during the interdialytic period. Inferior 
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vena cava (IVC) diameter was measured. Overhydration was defined 
as an IVC diameter of > 11.4 and underhydration as an IVC diameter 
of <8.0 mm/m2  [20,21]. Hypotension was defined as a drop in systolic 
blood pressure of >30% or below 100 mmHg. 
All dialysis treatments used a Fresenius 4008 H machine, 
biocompatible membranes (Hemophane or Polysulphone) and 
bicarbonate-buffered dialysate (Fresenius Medical Care SK-F213). 
Composition of dialysate: Na+ 138, K+ 2.00, Ca2+ 1.75, and HCO3- 
32.00 mmol/L. Four patients were dialyzed twice weekly, the others 3 
times a week. 
 
Echocardiography 
Two-dimensional echocardiography and Doppler studies were 
performed one hour before HD with UF and repeated one hour after 
the end of HD, assuming the process of plasma refilling to be 
completed by that time. These measurements were repeated twenty-
four hours after the initial echo Doppler in all but one subject.  
Echocardiograms were obtained using a General Electric Vingmed 
System 5 machine equipped with a 3.5 MHz transducer. The same 
experienced echocardiographer performed all measurements. LV mass 
was calculated from Penn convention measurements according to 
Devereux and Reichek [22]. LVMI by height was used for the diagnosis 
of LVH according to the Framingham Study. LVMI ≥143 g/m for men 
and ≥102 g/m for women was considered diagnostic of LVH [23,24]. 
Stroke volume (SV) and fractional shortening (FS) were calculated 
from measurements in M-mode of end-diastolic and end-systolic 
diameters in order to obtain an estimate of LV systolic function. 
Transmitral pulsed-wave Doppler velocities were recorded in the 
apical four chamber or apical long axis view. The sample volume was 
located at the tips of the mitral valve leaflets. Peak E and A 
transmitral flow velocities as well as deceleration time (DT) of early 
transmitral flow velocity were measured (Figure 1). Pulsed-wave 
Doppler velocities of systolic and diastolic forward flow were measured 
Chapter 4 
 76 
in the right upper PV. Using Doppler tissue imaging (DTI), in which 
the sample volume was located at the interventricular septal wall at 
the level of the mitral annulus, the velocities of motion of the mitral 
annulus were recorded  
 
 
Figure 1: Peak early (E) and atrial (A) transmitral pulsed-wave Doppler flow 
velocities and deceleration time (DT) of early transmitral flow velocity. 
Using Doppler tissue imaging (DTI), two distinct signals which are 
directed away from the LV centroid, are obtained during early (e) and 
late (a) diastole. Flow propagation velocity (Vp) is measured from color 
M-mode as the slope of the first aliasing velocity during early filling 
from the mitral valve plane into the LV cavity.  
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in spectral pulsed-mode. Diastolic dysfunction has been defined as e 
<8 cm/s [19]. Flow propagation velocity (Vp) was measured from color 
M-mode recordings. The M-mode cursor was positioned through the 
center of the transmitral flow, avoiding boundary regions, and aligned 
in the direction of the inflow jet. Diastolic dysfunction has been 
defined as Vp <45 cm/s [19]. 
Flow and tissue velocities were recorded on videotape, digitized and 
transferred to a magneto-optical disk. In an off-line workstation 5 
consecutive beats were analyzed, and mean velocity values were 
calculated in order to minimize the measurement variability resulting 
from respiration. 
 
Statistical analysis 
The change in each echo Doppler parameter before and after HD was 
analyzed by the Wilcoxon matched pairs test. A p-value of less than 
0.05 was considered to indicate statistical significance. Data are 
presented as median values and range. 
 
Results 
Five patients developed hypotension during the dialysis treatment. In 
these patients, UF was temporarily halted, patients were placed in 
supine position, but no fluid had to be infused in order to continue 
HD. Median UF volume was 2200 ml (1000 – 3781 ml). IVC diameter 
before was 10.3 mm/m2 (4.6 – 11.6 mm/m2), so there was no 
excessive overhydration. Median IVC diameter after HD was 9.7 
mm/m2 (4.0 – 11.0 mm/m2), and all patients reached dryweight. 
Serum calcium corrected for serum albumin was 2.35 mmol/L (2.17 – 
2.58 mmol/L) before HD and 2.82 mmol/L (2.60 – 3.10 mmol/L) at 
the end of HD. PTH was 114 ng/L (20 – 461 ng/L). LVMI measured 
before HD was 146 g/m (117 – 307 g/m) for men and 139 g/m (86 – 
196 g/m) for women. LVMI measurements after HD were not 
significantly different (157 g/m, 101 – 217 g/m for men; 136 g/m, 79 
– 148 g/m for women). Thus, 3 out of 4 men and 4 out of 5 women 
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met criteria for LVH as measured both before and after HD. The other 
3 had LVMI within normal range. 
SV (97 ml; 61-178 ml) and FS (33%; 24-43%) measured before HD 
indicated reasonable LV systolic function in most patients. SV (64 ml; 
39-115 ml) and FS (25%; 16-45%) were significantly lower (p<0.05) 
after HD. Seven patients had trace mitral regurgitation before HD. 
After HD five of them had no mitral regurgitation at all, while in two 
patients mitral regurgitation was unchanged. 
 
  
Table 1:  Echo parameters before and after hemodialysis 
 
 
 
 BEFORE HD AFTER HD  
  Median Range Median Range p 
IVC/BSA  mm/m2 10.3 4.6 - 11.6 9.7 4.0 - 11.0 < 0.01 
E  cm/s 65 50 - 91 52 36 - 75 < 0.01 
A cm/s 86 53 - 119 82 65 - 120 NS 
E / A  0.77 0.60 - 1.34 0.54 0.37 - 1.02 < 0.01 
DT s 217 130 - 383 251 166 - 312 NS 
PV s/d  1.80 1.25 - 2.68 2.15 1.08 - 3.90 < 0.01 
e cm/s 6 4 - 9 4 3 - 8 < 0.02 
a cm/s 10 5 - 14 10 4 - 14 NS 
e / a  0.56 0.40 - 1.05 0.40 0.26 - 0.96 < 0.01 
Vp cm/s 45 32 - 60 30 16 - 47 < 0.01  
 
IVC: inferior vena cava diameter; BSA: body surface area; E: peak early transmitral 
flow velocity; A: peak transmitral flow velocity during atrial contraction; DT: 
deceleration time of E; PV s/d: pulmonary vein flow, ratio of peak systolic to 
diastolic flow velocity; e: peak early diastolic mitral annulus velocity; a: peak 
diastolic mitral annulus velocity during atrial contraction; Vp: flow propagation 
velocity of early diastolic filling. 
 
 Diastolic Function Assessment in Hemodialysis 
 79
Five patients had trace to maximally 1+ aortic regurgitation, which 
did not change after HD. 
In all patients E/A after HD (0.54; 0.37-1.02) was significantly lower 
(p<0.01) than before HD (0.77; 0.60-1.34) (Table 1 and Figure 2). E 
decreased (p<0.01) whereas A did not. There was no significant 
change in DT of early transmitral flow velocity.  The systolic to 
diastolic (s/d) ratio of peak PV flow velocity after HD (2.15; 1.08-3.90) 
was significantly higher (p<0.01) than before HD (1.80; 1.25-2.68).  
 
 
Figure 2: Change in peak transmitral flow velocities (E and A), peak mitral 
annulus velocities (e and a) and flow propagation velocity (Vp) 
following hemodialysis.  
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Tissue e/a after HD (0.40; 0.26-0.96) was significantly lower (p<0.01) 
than before HD (0.56; 0.40-1.05). Tissue e decreased (p<0.02) 
whereas a did not. Vp after HD (30 cm/s; 16-47 cm/s) was 
significantly lower (p<0.01) than before HD (45 cm/s; 32-60 cm/s). 
Twenty-four hours after the initial measurements before HD, at the 
same time as the start of HD the previous day, values for E/A (0.59; 
0.37-1.23), PV s/d (1.85; 1.07-3.38), e/a (0.41; 0.27-1.06) and Vp (28 
cm/s; 23-33 cm/s) did not differ from those taken one hour after HD. 
IVC diameter twenty-four hours later (8.8 mm/m2; 4.0 – 11.6 mm/m2) 
was not significantly different from IVC diameter one hour after HD. 
 
Discussion 
The results of this study are in keeping with a masking effect of 
predialysis hypervolemia on the impairment of early LV diastolic 
filling, resulting in pseudonormalization of transmitral blood flow 
pattern. After HD, in all patients the E/A ratio was reduced due to a 
significant decrease in peak E velocity. After reaching dryweight, all 
but one of the patients had E/A ratios consistent with LV diastolic 
dysfunction. The following day E/A was not significantly different 
from E/A one hour after HD. As the IVC diameter the following day 
was also not significantly different from the IVC diameter one hour 
after HD, it appears that relative overhydration leading to 
pseudonormalization occurs shortly before the start of HD. 
Seven patients had trace mitral regurgitation before HD, which may 
have augmented pseudonormalization by increasing left atrial 
pressure. This mild mitral regurgitation might have been caused by 
increased LV stretch due to volume overload, since it was 
undetectable in five patients after volume withdrawal.  
A pattern of preload dependence was also found in PV Doppler 
imaging. The preload dependence of conventional transmitral and PV 
flow measurements is a well-recognized phenomenon, which hampers 
the assessment of diastolic function in HD patients. Preload is the 
degree of stretch of the cardiac muscle at the start of LV contraction, 
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which depends on the degree of end-diastolic ventricular filling. Peak 
transmitral flow is the result of the combined effects of end-systolic 
left atrial pressure and the LV pressure-volume relationship. This 
pressure-volume relationship depends on the intrinsic LV 
characteristics of relaxation and compliance, and determines the LV 
pressure for a certain degree of ventricular filling. A preload-
independent measurement of LV diastolic function would be expected 
to reflect LV relaxation and compliance only. 
Unexpectedly, the newer techniques DTI and color M-mode Doppler, 
which have been proposed as relatively “preload-independent” echo 
Doppler parameters, exhibited a pattern of preload dependence 
similar to that displayed by the conventional pulsed-wave Doppler 
flow velocity measurements. It is possible that these newer techniques 
are preload-independent within certain physiological limits only.  
In DTI, as in transmitral flow measurements, the increase in e/a ratio 
before HD was due to a significant increase in early diastolic 
velocities. Nevertheless, median e before HD was already indicative of 
diastolic dysfunction. Likewise, using color M-mode, Vp before HD 
indicated borderline diastolic function. Both Doppler parameters 
showed a further deterioration after HD, which persisted the next day.  
In view of the demonstrated preload dependence, it is important that 
when measurements of LV diastolic function in HD patients are 
reported, both the time relation and the volume status should be 
specified. It seems preferable to assess diastolic function in a 
relatively normovolemic state, at least one hour after HD.  
Alternatively, DTI may reflect the actual diastolic function, which 
would imply that HD impairs cardiac relaxation and thereby worsens 
LV diastolic function. This could be caused by the shift in serum 
ionized calcium concentration during HD. Decreased availability of 
calcium to the myocardium could impair both myocardial contraction 
and relaxation. Doppler parameters the following day were not 
different from those measured one hour after HD. Therefore, it seems 
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less likely that acute changes related to the shifts in solutes caused 
the deterioration of diastolic function.  
The decrease in SV and FS indicated a deterioration of LV systolic 
function following HD. Such a change in systolic function is another 
variable with a potential adverse effect on diastolic function. LV 
systolic function was previously found to be normal and to remain 
unchanged after HD [10,25]. However, different measures of cardiac 
pump function have been used, some of which are affected by volume 
changes, as may have been the case in our population. So even 
though myocardial contractility seemed to remain unchanged or even 
slightly improved in some studies, this effect was limited due to the 
load dependence of commonly used measures of LV systolic function 
[26,27].  
Due to LV diastolic dysfunction, adequate cardiac filling can only be 
achieved in these patients at high levels of left atrial filling pressure. 
However, in these patients, who are dependent on high levels of filling 
pressure, venous return is reduced by UF during HD. The 
demonstrated LV diastolic dysfunction could therefore play an 
important role in the pathogenesis of dialysis-related hypotension. 
We conclude, that even when using the newer Doppler techniques DTI 
and color M-mode, pseudonormalization due to volume overload 
before HD resulted in underestimation of the degree of diastolic 
dysfunction. Therefore, the advantage of these techniques over 
conventional parameters for the assessment of LV diastolic function 
in HD patients is limited. These parameters can be useful, provided 
that information on their time relation to the HD process is reported, 
and that they are not used on the day of the dialysis treatment before 
HD.  
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Abstract 
An increase in serum Ca2+ during hemodialysis (HD) may lead to 
impaired left ventricular (LV) relaxation. Since LV diastolic function 
assessment in dialysis patients is hampered by preload dependence of 
Doppler measurements, we tested the effect of HD without 
ultrafiltration (UF) on these measurements. 
Transmitral E and A velocities, and mitral annulus e and a velocities 
were measured in ten patients before and after 1 hour of HD without 
UF. Dialysate Ca2+ was 1.75 mmol/L.  
Serum Ca2+after 1 hour (1.31 mmol/L; 1.28-1.46 mmol/L) was higher 
(p=0.002) than before HD (1.24 mmol/L; 1.09-1.32 mmol/L). E/A 
(0.8; 0.4-2.8) and e/a (0.7; 0.4-1.3) after 1 hour were not different 
than E/A (0.8; 0.6-5.1) and e/a (0.7; 0.4-1.8) before HD.  
The increase in serum Ca2+ does not lead to a change in Doppler 
parameters of LV diastolic function. Changes in these parameters 
after combined HD-UF are related to preload, not to serum Ca2+. 
 
Introduction 
Left ventricular (LV) diastolic dysfunction is considered to be an 
important factor in the pathogenesis of intradialytic hypotension. An 
increase in serum ionized calcium concentration in the course of the 
hemodialysis (HD) procedure could lead to impaired cardiac 
relaxation. A dialysate solution with a calcium concentration of 1.75 
mmol/L is frequently used to prevent a negative calcium balance, 
especially in dialysis patients using phosphate binders that do not 
contain calcium. The resulting increase in serum ionized calcium may 
account for the changes in Doppler parameters of LV diastolic 
function we observed during echocardiography shortly after HD [1]. 
However, the diagnosis of LV diastolic dysfunction is not easy to 
establish in the HD population. Accurate echocardiographic 
assessment of LV diastolic function in dialysis patients is hampered 
by the preload dependence of conventional Doppler transmitral flow 
measurements [2,3]. A new Doppler technique, mitral annulus 
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velocity by Doppler Tissue Imaging (DTI), has been proposed as a 
relatively preload-independent parameter of LV diastolic function [4-
6]. However, we recently showed this Doppler parameter to display a 
similar pattern of preload dependence [1]. Volume status is therefore 
a confounding factor in dialysis patients, in whom filling pressures 
change independent of a change in cardiac function, as the volume 
status is directly altered by ultrafiltration (UF). Predialysis 
overhydration leads to a high preload, which may mask impairment of 
early diastolic filling. Conversely, HD with UF reduces preload, 
resulting in decreased peak early filling velocities and a pattern of 
diastolic dysfunction. So it is clear, that in the assessment of LV 
diastolic function in dialysis patients, the effect of preload changes is 
crucial and must be accounted for. We therefore focused on the effect 
of dialysis-induced calcium changes on LV diastolic function in the 
absence of volume status alteration. In the present study, we tested 
the effect of isolated diffusive HD without UF on transmitral flow 
measurements and mitral annulus velocity by DTI.  
 
Methods 
Patients 
Ten HD patients (8 men and 2 women, median age 60 years, range 37 
to 77 years) were included in this study. Median time on HD was 11 
months (range 2 to 59 months). One patient had undergone coronary 
artery bypass graft surgery thirteen years before, and percutaneous 
transluminal coronary angioplasty (PTCA) with stent placement three 
years before. One patient had a history of unstable angina pectoris 
treated successfully by PTCA with stent placement two years before. 
Eight patients had no history of cardiac disease. None of the patients 
had symptomatic ischemic heart disease, significant (>1+) valvular 
disease or congestive heart failure.  
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Hemodialysis 
All patients were dialyzed following a standard dialysis prescription, 
which had remained unchanged for several weeks. Dry weight was 
considered optimal when patients remained without symptoms of 
dyspnea, orthopnea or edema during the interdialytic period.  
All dialysis treatments used a Fresenius 4008 H machine, 
biocompatible membranes (Hemophane or Polysulphone) and 
bicarbonate-buffered dialysate (Fresenius Medical Care SK-F213). 
Standard dialysate was used in all patients. Composition was as 
follows: Ca2+ 1.75, Na+ 138, K+ 2.00, and HCO3- 32.00 mmol/L.  
 
Study design 
The duration of the dialysis procedure was 4 hours in all patients. 
During the first hour, no UF took place. Two-dimensional 
echocardiography and Doppler studies were performed before HD and 
after 1 hour. Thereafter, the dialysis session was continued following 
their dialysis prescription, which included UF. Serum ionized calcium 
concentration was measured at before, after 1 hour of HD and after 4 
hours at the end of HD. 
 
Echocardiography 
Echocardiograms were obtained using a Hewlett Packard Sonos 5500 
machine equipped with a 3.5 MHz transducer (Hewlett Packard, 
Andover, MA). The same experienced echocardiographer performed all 
measurements. LV dimensions were measured from the apical four-
chamber or parasternal long-axis view. LV mass is reported as LV 
mass index (LVMI) by height according to the Framingham Study [7]. 
Fractional shortening (FS) of the LV short axis was measured to 
obtain an estimate of LV systolic function. Transmitral pulsed-wave 
Doppler flow velocities were recorded in the apical four-chamber or 
apical long-axis view. The sample volume was located at the tips of 
the mitral valve leaflets. Peak E and A transmitral flow velocities were 
measured (Figure 1). With the use of DTI, in which the sample volume 
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was located at the interventricular septal wall at the level of the mitral 
annulus, the velocities of motion of the mitral annulus were recorded 
in spectral pulsed-mode. Data were recorded on videotape, digitized 
and transferred to a magneto-optical disk. In an off-line workstation, 
five consecutive beats were analyzed, and mean velocity values were 
calculated in order to minimize the measurement variability resulting 
from respiration. 
 
 
 
Figure 1: Peak early (E) and atrial (A) transmitral pulsed-wave Doppler 
velocities. Using Doppler tissue imaging (DTI), two distinct signals 
that are directed away from the LV centroid, are obtained during early 
(e) and late (a) diastole. 
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Statistical analysis 
The changes in echo Doppler parameters before and after 1 hour of 
dialysis were analyzed by the Wilcoxon matched pairs test. The serial 
measurements of serum ionized calcium before, after 1 hour and at 
the end of HD were compared using Friedman’s ANOVA by ranks. If 
significant, this was followed by a post hoc test using Dunn’s 
analysis. A p < 0.05 was considered to indicate statistical significance. 
Data are presented as median values and range. 
 
 
Table 1: Serum ionized Ca2+ concentration (mmol/L) at baseline, after 1 hour 
of HD without UF, and after 4 hours of HD, using a dialysate with 
Ca2+ 1.75 mmol/L.  
 
 
Patient Baseline After 1 hour After 4 hours 
1 1.18 1.31 1.28 
2 1.15 1.28 1.31 
3 1.21 1.31 1.40 
4 1.24 1.46 1.48 
5 1.23 1.33 1.38 
6 1.27 1.29 1.24 
7 1.32 1.40 1.45 
8 1.27 1.30 1.36 
9 1.09 1.29 1.41 
10 1.24 1.35 1.37 
Median 1.22 1.33a 1.37ab 
 
 
a Ca2+ after 1 hour and after 4 hours are significantly (p<0.05) different from 
baseline. b Ca2+ after 4 hours is not significantly different from Ca2+ after 1 hour. 
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Results 
The dialysis sessions in all patients were uneventful, and none of the 
patients complained of cramps. At baseline, before HD was initiated, 
the serum ionized calcium concentration was within the normal range 
in all but one of the patients (1.24 mmol/L; 1.09-1.32 mmol/L) (Table 
1). Serum ionized calcium after 1 hour (1.31 mmol/L; 1.28-1.46 
mmol/L) was significantly higher (p=0.002). There was a further rise 
in serum ionized calcium until the end of HD after 4 hours (1.38 
mmol/L; 1.24-1.48 mmol/L), which was not significant. Hematocrit 
(0.32; 0.25-0.35) and serum protein (65 g/L; 59-71 g/L) after 1 hour 
were not different from hematocrit (0.33; 0.27-0.36) and serum 
protein (69 g/L; 60-71 g/L) at baseline. 
LVMI at baseline was 128 g/m (86-210 g/m). LV end-diastolic 
diameter (EDD) (44 mm; 32-55 mm) and FS (35 %; 11-44 %) after 1 
hour HD without UF was not different than EDD (44 mm; 39-58 mm) 
and FS (36 %; 13-48 %) before HD. Ejection fraction (EF) after 1 hour 
HD without UF (72%; 30-82%) was not different than at baseline 
(72%; 34-86%). Transmitral E/A after 1 hour HD without UF (0.8; 
0.4-2.8) was not different than before HD (0.8; 0.6-5.1). Likewise, 
tissue e/a after 1 hour HD without UF (0.7; 0.4-1.3) was not different 
than before HD (0.7; 0.4-1.8) (Table 2). 
 
 
Discussion 
In all patients, a one-hour dialysis session, with a 1.75 mmol/L 
dialysate calcium concentration, resulted in a significant increase in 
the serum ionized calcium concentration. This had no effect on 
transmitral Doppler flow velocities or mitral annulus velocity by DTI. 
The results of this study show that echo Doppler parameters of LV 
diastolic function do not change during dialysis without UF, despite a 
marked increase in serum ionized calcium concentration. 
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Table 2: Serum ionized calcium concentration (Ca2+), fractional shortening 
(FS) and Doppler parameters before and after 1 hour of hemodialysis 
(HD) without ultrafiltration (UF). 
 
 
 
 BASELINE AFTER 1 hr HD - UF  
  Median Range Median Range P 
Ca2+ mmol/L 1.24 1.09-1.31 1.31 1.28-1.46 0.002 
FS % 36 13-48 35 11-44 NS 
E cm/s 68 41-168 58 33-164 NS 
A cm/s 77 33-125 76 56-135 NS 
E / A  0.8 0.6-5.1 0.8 0.4-2.8 NS 
e cm/s 6.5 3.4-9.1 6.5 3.0-7.9 NS 
a cm/s 9.0 3.3-13.8 9.4 3.9-11.8 NS 
e / a  0.7 0.4-1.8 0.7 0.4-1.3 NS 
 
 
 
Few studies testing the effect of changes in serum ionized calcium 
concentration on cardiac function in HD patients have been done. SV  
measured as a parameter of LV systolic function was found to 
decrease after HD. This decrease was smaller with a higher dialysate 
calcium concentration [8,9]. In these studies, UF was a confounding 
factor. In our study, visual assessment of LV wall motion before and 
after HD without UF did not reveal a marked change in contraction 
pattern. This was confirmed by measuring FS from these two-
dimensional images, which did not change. Measurement of LV 
ejection fraction (EF) is widely used and generally accepted as 
parameter of LV systolic function [10]. Median EF in this group was 
normal and did not change after HD without UF. From these results, 
it appears that LV contraction is not directly affected by a significant 
increase in serum ionized calcium. 
Only two studies focused on the effect on LV diastolic function. In one 
of these [11], calcium gluconate was infused at a constant rate of 45 
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µmol/kg/h to 14 patients with moderate to severe chronic renal 
failure and secondary hyperparathyroidism. There were no HD 
patients included in this study. The study population had LV diastolic 
indices which were not different from a healthy control group, and 
baseline E/A was 1.552, considerably higher than expected in a 
dialysis population. There was a minor decrease in E/A from 1.552 to 
1.414 after calcium infusion. With the use of Student’s t-test, the 
authors found this decrease to be significant (p=0.03), although a 
non-parametric approach might have been more appropriate in view 
of the small number of patients included. The authors aimed at 
reaching supranormal levels of serum ionized calcium concentration. 
The infusion resulted in an increase in mean serum ionized calcium 
from 1.18 to 1.40 mmol/L. Regarding both the study population and 
the infusion of calcium to supranormal levels, the experimental 
conditions of this study clearly do not reflect the setting of a regular 
dialysis session, such as in our study. We measured the serum 
calcium concentration at the end of the HD procedure after four 
hours, and observed a modest non-significant further increase in 
serum ionized calcium in most, but not all, patients. This indicates 
that the diffusion of calcium ions is greatest in the first hour of 
dialysis. 
In another study by the same group [12], transmitral flow velocity 
measurements were made in 12 HD patients before and after three 
HD sessions with dialysate calcium concentrations of 1.25, 1.50 and 
1.75 mmol/L. Serum ionized calcium increased significantly in the 
1.50 and 1.75 sessions. Unfortunately, during all sessions, volume 
was also withdrawn, thereby introducing a confounding factor in this 
study. Mean total UF varied from 2120 to 2580 ml. In view of the well-
known phenomenon of preload dependence of transmitral flow 
velocity measurements, the E/A ratio could be expected to be lower 
after HD. Indeed, this was the case in all sessions, and it was due to a 
decrease in peak early velocity (E). However, there was a wide 
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standard deviation, and the differences were not significant, except 
after the 1.75 mmol/L session.  
The utility of transmitral flow velocity measurement as a Doppler 
parameter of LV diastolic function in HD patients is limited by its 
preload dependence. In our study, the effect of changes in volume 
status was precluded, as there was no UF during the first hour.  The 
absence of changes in hematocrit and serum protein indicates that 
volume shifts resulting from a dialysate-plasma sodium gradient were 
negligible. We also included mitral annulus velocity measurements by 
DTI. Although we recently demonstrated this technique to be preload-
dependent as well, a change in mitral annulus velocity by DTI, in the 
absence of UF, may only reflect changes in myocardial tissue 
relaxation. This could be caused by the shift in serum ionized calcium 
during diffusive HD. However, as there was no change in e, a or e/a, 
this newer Doppler parameter of LV diastolic function follows the 
same pattern as the conventional pulsed-wave Doppler flow velocity 
measurements. This finding contradicts the view that an increase in 
serum ionized calcium concentration during a standard dialysis 
session would lead to impaired LV relaxation. 
We conclude that the increase in serum ionized calcium 
concentration, resulting from diffusive dialysis with a dialysate 
calcium concentration of 1.75 mmol/L, does not lead to a change in 
pulsed-wave Doppler transmitral flow velocity or mitral annulus 
velocity by DTI. These results confirm our hypothesis, that changes in 
Doppler echocardiography parameters of LV diastolic function after a 
standard HD procedure with UF are related to preload, and not to the 
increase in serum ionized calcium concentration.  
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Abstract 
An elevated pulse pressure leads to an increased pulsatile cardiac 
load, and results from arterial stiffening. The aim of our study was to 
test whether a reduction in volume overload by ultrafiltration (UF) 
during hemodialysis (HD) leads to an improvement of aortic 
compliance. 
In 18 patients, aortic compliance was estimated non-invasively before 
and after HD with UF using a pulse pressure method based on the 
Windkessel model. This technique has not been applied before in a 
dialysis population, and combines carotid pulse contour analysis by 
applanation tonometry with aortic outflow measurements by Doppler 
echocardiography.  
Median UF volume was 2450 ml (range 1000 to 4000 ml). Aortic 
outflow volume after HD (39 ml; 32-53 ml) was lower (p=0.01) than 
before (46 ml; 29-60 ml). Carotid pulse pressure after HD (42 mmHg; 
25-85 mmHg) was lower (p=0.01) than before (46 mmHg; 35-93 
mmHg). Carotid augmentation index after HD (22%; 3-30%) was lower 
(p=0.001) than before (31%; 7-53%). Carotid-femoral pulse wave 
velocity was not different after HD (8.7 m/s; 5.6-28.9 m/s vs. 7.7 
m/s; 4.7-36.8 m/s). Aortic compliance after HD (1.10 ml/mmHg; 
0.60-2.43 ml/mmHg) was higher (p=0.02) than before (1.05 
ml/mmHg; 0.45-1.69 ml/mmHg).  
The increase in aortic stiffness in HD patients is partly caused by a 
reversible reduction of aortic compliance due to volume expansion. 
Volume withdrawal by HD moves the arterial wall characteristics back 
to a more favorable position on the non-linear pressure-volume curve, 
reflected in a concomitant decrease in arterial pressure and improved 
aortic compliance. 
 
Introduction 
Systolic hypertension is highly prevalent in the hemodialysis (HD) 
population. As diastolic blood pressure (BP) is usually normal, this 
results in an elevated pulse pressure, which is an independent 
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cardiovascular risk factor [1,2,3]. While total peripheral resistance 
reflects the non-pulsatile cardiac load, an elevated pulse pressure 
reflects a decrease in arterial cushioning function and, consequently, 
an increase in pulsatile load. This results from arterial stiffening, 
which normally occurs with increasing age [4]. Patients with renal 
failure therefore seem to suffer from premature arterial aging. 
Structural vascular changes include increased (intimal) 
atherosclerosis, which is enhanced by the disadvantageous 
cardiovascular risk profile in end-stage renal disease (ESRD), and 
increased (medial) arteriosclerosis, which is related to calcification 
and chronic volume overload [5,6]. Functional changes include an 
increased arterial tone induced by angiotensin II [7], increased plasma 
endothelin 1 levels [8], and impaired nitric oxide synthesis resulting 
from accumulation of endogenous asymmetrical dimethylarginine 
(ADMA) in ESRD [9]. Both structural and functional abnormalities of 
the arterial system affect the arterial pressure wave contour. The 
forward traveling pressure wave results in an initial systolic rise. 
Decreased compliance of central arteries, such as the aorta and 
common carotid artery, leads to a decreased Windkessel effect with a 
higher incident systolic peak pressure. It also leads to an increase in 
aortic pulse wave velocity (PWV) of both propagated and backward 
traveling (reflected) pressure waves. Earlier wave reflection changes 
the phase relationship between the propagated and reflected wave. 
The resulting central arterial wave contour increasingly resembles a 
peripheral arterial wave contour, with a second systolic BP rise 
augmenting peak systolic pressure instead of diastolic pressure.  
Several markers associated with increased central arterial stiffness 
have been shown to be predictors of mortality in the dialysis 
population, including carotid pulse pressure [10], carotid incremental 
elastic modulus [11], carotid-femoral PWV [12,13] and carotid 
augmentation index [14]. In HD patients, factors such as anuria, 
anemia and the presence of an arteriovenous fistula lead to chronic 
volume overload. In addition, reduced aortic compliance results in 
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chronic pressure overload. This promotes the development of LV 
hypertrophy, and may lead to both diastolic dysfunction and a 
reduced coronary perfusion. Coronary perfusion may be further 
worsened by a reduced coronary perfusion pressure due to the lower 
diastolic BP. 
The aim of our study was to test whether a reduction in volume 
overload by ultrafiltration (UF) during HD leads to an improvement of 
aortic compliance. We estimated aortic compliance non-invasively 
before and after HD with the use of a pulse pressure method based on 
the Windkessel model [15]. This technique has not been applied 
before in a dialysis population. With the use of echocardiography, 
Doppler-derived aortic outflow volume measurement is combined with 
an estimation of aortic pulse pressure obtained by carotid pulse 
contour analysis using applanation tonometry. Changes in pressure-
volume relations are measured close to the LV outflow tract, reflecting 
changes in the cushioning function of the aorta, and hence, of the 
pulsatile cardiac load, an important determinant of LV afterload.  
 
Methods 
Study population 
Eighteen HD patients (nine men and nine women, median age 54, 
range 30-85 years) were included in this study. Median time on HD 
was 31 months (range 4-106 months). Hypertensive medication, 
including calcium-antagonists in four patients, an angiotensin-
converting-enzyme inhibitor (1), and angiotensin II receptor blockers 
(4), had been withheld since the previous dialysis session, two days 
before the measurements. Four patients used betablockers, which 
were continued. On the day of the measurements, patients refrained 
from smoking and did not use caffeine-containing beverages. The 
study protocol was approved by the institutional review committee of 
our hospital and written informed consent was obtained from all 
patients. 
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Hemodialysis 
All patients were dialyzed three times a week according to a standard 
dialysis prescription, which had been unchanged for several weeks. 
Dry weight was considered optimal when patients remained without 
symptoms of dyspnea, orthopnea or edema during the interdialytic 
period. Inferior vena cava diameter (IVCD) was measured with 
patients in supine position during quiet expiration. Indexed by body 
surface area, overhydration was defined as an IVCD of > 11.4 mm/m2 
and underhydration as an IVCD of <8.0 mm/m2 [16,17]. Hypotension 
was defined as a drop in systolic (SBP) of >30% or below 100 mmHg. 
All dialysis treatments used Fresenius 4008 machines (Fresenius 
Medical Care, Bad Homburg, Germany), biocompatible membranes 
(Hemophane or Polysulphone) and bicarbonate-buffered dialysate 
(Fresenius Medical Care SK-F213).  
 
Blood pressure measurement 
Sphygmomanometric brachial BP was measured with the use of the 
Datascope Accutorr Plus™ (Datascope Corp., Paramus, NJ). After a 
rest period of 5 minutes in recumbent position, three consecutive 
readings were made, and the average value for SBP, diastolic BP 
(DBP) and mean BP were taken. A regular cuff size was adequate in 
all patients, and was positioned just above the elbow in the nonfistula 
arm. Patients were in a recumbent position. 
 
Vascular parameters 
Measurements were made one hour before and one hour after HD. In 
a subset of eight patients measurements were repeated twenty-four 
hours after the initial measurements before HD. Pressure 
measurements and echocardiographic measurements were performed 
by two separate investigators. Pressure curves were obtained with the 
use of a pen-like transducer for applanation tonometry (Millar SPT-
301, Millar Instruments Inc., Houston, TX) of the carotid and femoral 
artery. Calibration used mean and diastolic sphygmomanometric 
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brachial BP. Carotid BP was assumed to be similar to aortic BP, as 
invasive recordings have shown a high correlation between carotid 
and aortic recordings [18]. Aortic compliance was calculated with a 
pulse pressure method combining carotid tonometry signals with echo 
Doppler-derived aortic outflow measurements. This method is based 
on an iterative search of the best fit between the measured pulse 
pressure and the pulse pressure predicted by a 2-element Windkessel. 
Inputs of the Windkessel were measured pulse pressure and aortic 
flow (Figure 1). Aortic outflow volume was measured by 
echocardiography in the LV outflow tract. This is the product of the 
aortic annulus area (cm2) from a parasternal long axis view and the 
Doppler outflow velocity – ejection time integral (VTI: [cm/s]*s) from 
an apical four-chamber view.  
 
Echocardiographic measurements 
An experienced echocardiographer performed all echocardiographic 
measurements using a Hewlett Packard Sonos 5500 machine (Hewlett 
Packard, Andover, MA). At baseline, LV dimensions were measured 
from the apical four-chamber or parasternal long-axis view. LV mass 
is reported as LV mass index (LVMI) by height according to the 
Framingham Study [19]. As described above, the aortic outflow 
volume was measured in the LV outflow tract, which in the absence of 
significant valvular regurgitation equals stroke volume (SV). Ejection 
fraction (EF) were measured as additional parameters of LV systolic 
function. Transmitral pulsed-wave Doppler flow velocities were 
recorded in the apical four-chamber or apical long-axis view. The 
sample volume was located at the tips of the mitral valve leaflets. Peak 
E and A transmitral flow velocities were measured to obtain an E/A 
ratio as measure of LV diastolic function. 
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Figure 1: Combined measurements of carotid pressure (P) wave by applanation 
  tonometry and aortic outflow velocity (Ao) by echo Doppler for the  
  calculation of aortic compliance, with the use of a pulse pressure  
  method. Aortic outflow volume (ml) is the product of the left  
  ventricular outflow tract area (cm2) and the velocity-time integral  
  (VTI) of the aortic outflow (cm). Aug:  augmentation. 
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Analysis of wave contours 
The echo Doppler and tonometric signals were simultaneously 
acquired with an analogue/digital board and a laptop running 
customized software for spectral recomputation and automatic 
detection of maximal velocity.  For analysis of wave contours, at least 
seven consecutive cardiac cycles were measured. Aortic PWV was 
computed from realigned carotid and femoral tonometry signals, 
simultaneous ECG recording and sternal notch-femoral distance. 
Augmentation of carotid systolic pressure was expressed as carotid 
augmentation index (AIC), which is the height of the second BP rise 
above the inclination point in the carotid pressure wave contour 
divided by carotid pulse pressure. 
 
Statistical analysis 
The change in vascular and hemodynamic parameters before and 
after HD was analyzed by the Wilcoxon matched pairs test. For 
assessing correlation the Spearman correlation coefficient was used. A 
p-value of less than 0.05 was considered to indicate statistical 
significance. Data are presented as median values and range. 
 
Results 
Echocardiographic parameters at baseline were as follows: LVMI in 
men 141 g/m (117-196 g/m) and in women 141 g/m (86-195 g/m). 
EF was 71% (56-81%). E/A was 0.8 (0.6-1.3). IVC diameter at 
baseline was 10.5 mm/m2 (6.4 – 11.6 mm/m2), so there was no 
excessive overhydration before the start of HD. Median IVC diameter 
after HD was 9.8 mm/m2 (4.2 – 11.0 mm/m2), and all patients 
reached dryweight. Three patients developed hypotension during the 
dialysis treatment. In these patients, UF was temporarily halted, 
patients were placed in supine position, but no fluid had to be infused 
in order to continue HD. Median UF volume was 2450 ml (1000 – 
4000 ml).  
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Table 1:  Hemodynamic and vascular parameters before and after   
  hemodialysis 
 
  BEFORE HD AFTER HD  
  Median Range Median Range p 
SBP mmHg 142 105-184 128 98-184 0.01 
DBP mmHg 85 69-94 80 60-93 NS 
HR min-1 75 54-87 79 57-100 NS 
Ao Vol ml 46 29-60 39 32-53 0.01 
Car PP mmHg 46 35-93 42 25-85 0.01 
AIC % 31 7-53 22 3-30 0.001 
PWV m/s 8.7 5.6-28.9 7.7 4.7-36.8 NS 
COMPL ml/mmHg 1.05 0.45-1.69 1.10 0.60-2.43 0.02 
 
 
SBP : brachial systolic blood pressure; DBP: brachial diastolic blood pressure; HR: 
heart rate; Ao Vol: aortic outflow volume; Car PP: carotid pulse pressure;  AIC: 
carotid augmentation index; PWV: carotid-femoral pulse wave velocity; COMPL: 
aortic compliance. 
 
SBP after HD (128 mmHg; 98-184 mmHg) was lower (p=0.01) than 
before HD (142 mmHg; 105-184 mmHg) (Table 1). DBP after HD (80 
mmHg; 60-93 mmHg) was not different from DBP before HD (85 
mmHg; 69-94 mmHg). Heart rate (HR) after HD (79 min-1; 57-100 
min-1) was not different from HR before HD (75 min-1; 54-87 min-1).  
Aortic outflow volume after HD (39 ml; 32-53 ml) was lower (p=0.01) 
than before (46 ml; 29-60 ml). At baseline, all patients showed carotid 
wave contours with augmentation. Carotid pulse pressure after HD 
(42 mmHg; 25-85 mmHg) was lower (p=0.01) than before (46 mmHg; 
35-93 mmHg).  AIC after HD (22%; 3-30%) was significantly lower 
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(p=0.001) than before (31%; 7-53%). Carotid-femoral PWV was not 
significantly different after HD (8.7 m/s; 5.6-28.9 m/s vs. 7.7 m/s; 
4.7-36.8 m/s). Aortic compliance was negatively correlated with PWV 
before HD (r= -0.6; p=0.02) and after HD (r= -0.6; p=0.02). Aortic 
compliance after HD (1.10 ml/mmHg; 0.60-2.43 ml/mmHg) was 
significantly higher (p=0.02) than before HD (1.05 ml/mmHg; 0.45-
1.69 ml/mmHg).  
In the subgroup in which measurements were repeated the day after 
HD, values one hour after HD were: AIC 19% (11-30%), PWV 7.3 m/s 
(4.7-23.3 m/s), and aortic compliance 1.66 ml/mmHg (0.86-2.43 
ml/mmHg). Twenty-four hours after the initial measurements before 
HD, values were: AIC 20% (12-29%), PWV 7.6 m/s (4.9-24.3 m/s), 
and aortic compliance 1.49 ml/mmHg (0.99-1.95 ml/mmHg). None of 
the tonometry parameters showed a significant difference between 
measurements taken after one hour and one day after HD.  
 
Discussion 
The results of this study show improvement in arterial wall pressure-
volume relations after reduction of volume overload by UF. There was 
a significant increase in aortic compliance after HD and a significant 
decline in SBP, but no change in DBP. These results demonstrate that 
in HD patients the increase in aortic stiffness is partly reversible.  
Studies testing the effect of rapid fluid withdrawal on arterial wall 
characteristics are few and show variable results (Table 2). This partly 
depends on the parameter used. As seen in our study, AIC has been 
shown to decrease after HD with UF [7,20]. When carotid-femoral 
PWV was used as a marker of aortic stiffness, no direct effect of fluid 
withdrawal was found in previous studies [7,21]. This is in agreement 
with our study in which there was no significant change in carotid-
femoral PWV after HD with UF. The variability of our results for PWV 
may be partly responsible for this, although there was a trend toward 
a decrease after HD. In a previous study, UF combined with 
angiotensin-converting-enzyme inhibition did show a significant  
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Table 2: Changes in pulse pressure and in different vascular parameters after 
volume withdrawal by hemodialysis. The change in pressure-volume 
relation by pulse pressure method shows improved compliance after 
volume withdrawal with concomitant decrease in pulse pressure.  
 
 
   Direct parameters Indirect parameters 
Studies Ref. PP COMPL Car DIST AIC PWV 
Previous 7 ↓ not measured ↓ = 
 20 ↓ not measured ↓  
 21 ↑  ↓  = 
 27 =  =   
Present  ↓ ↑  ↓ = 
 
Ref: references of studies quoted in Discussion; PP: pulse pressure; Direct 
parameters: measure arterial pressure-volume relations; Indirect parameters: are 
codetermined by arterial wall properties; COMPL:  aortic compliance; Car DIST: 
carotid distensibility; AIC: carotid augmentation index; PWV: carotid-femoral pulse 
wave velocity. 
 
 
decrease in carotid-femoral PWV, which was explained by an acute 
effect on angiotensin II activity [7].  
Both increased PWV and augmentation have been shown to be 
important predictors of cardiovascular morbidity and mortality. 
Although they result from altered mechanical properties of arteries, 
neither provides direct information on those properties [22]. AIC is a 
manifestation of arterial stiffness, and is influenced by confounding 
factors such as HR, age, gender and height [23], although in our study 
HR did not change significantly. The function of small muscular 
arteries and arterioles can also affect AIC by changing the aortic wave 
reflection pattern independent of aortic PWV [24]. Aortic PWV is 
usually measured between the carotid and femoral artery as a 
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parameter of segmental arterial stiffness. However, PWV is 
proportional to the square root of the product of wall elastance and 
thickness. As a result of this square root relationship, PWV is not a 
sensitive measure of a change in physical arterial properties [25,26]. 
In the dialysis patients in our study, changes in pressure-volume 
relations close to the LV outflow tract are estimated with the use of a 
pulse pressure method. Compliance is a direct measure of arterial 
elastic properties. It describes arterial stiffness as an absolute volume 
(or diameter) change for a given pressure increment. The improved 
aortic compliance following volume withdrawal in our study signifies a 
decrease in LV afterload resulting from a reduction in pulsatile load.  
An inherent characteristic of a method for measuring compliance is 
that it depends on both changes in volume and changes in pressure. 
In this study population, as a consequence of UF, there is primarily a 
change in aortic outflow volume. Subsequently, there is a change in 
aortic pulse pressure. Since the arterial pressure-volume relationship 
is non-linear, compliance increases as pressure decreases. This is 
because at higher pressure, wall tension is mainly generated by 
collagen fibers, but at lower pressure by elastin fibers, which are more 
distensible [3,6]. Therefore, overhydration per se can lead to increased  
aortic stiffness. In the subgroup that was measured the following day, 
the improvement of arterial wall characteristics was sustained. This 
finding suggests that relative overhydration leading to increased 
arterial stiffness occurs shortly before the start of HD. 
The UF-induced increase in compliance may have resulted from 
changes independent of pressure, which we were unable to detect in 
the present study design. In two previous studies, the parameter 
carotid distensibility, another direct measure of arterial stiffness, was 
used to monitor changes in arterial wall characteristics after HD. It 
describes arterial stiffness as relative, rather than absolute, diameter 
change for a pressure increment. In one study, pulse pressure 
increased rather than decreased, although not significantly, and 
carotid distensibility decreased after HD [21]. This was despite a mean 
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UF volume of 1460 ml. The authors suggested this might be due to 
sympathetic activation, as there was no change in distensibility when 
corrected for pressure. In the other study, there was no significant 
change in carotid distensibility or in BP and pulse pressure, despite a 
mean UF volume of 4000 ml [27]. It would therefore appear that, 
when volume reduction by UF does not lead to a decrease in pressure, 
other factors leading to functional changes of the arterial wall offset 
the beneficial effect of volume withdrawal [21]. 
Although volume withdrawal in our study had an acute, albeit small, 
impact on arterial wall characteristics, high PWV values and marked 
augmentation continued to be present after HD. This indicates that 
the acute large swing in volume status before and after HD affects 
arterial stiffness on top of a more permanent alteration in arterial 
structure and function, which is likely to be caused by chronic 
volume overload [28]. 
We conclude that the increase in aortic stiffness in HD patients is 
partly caused by a reversible reduction in aortic compliance resulting 
from volume expansion. Volume withdrawal by HD moves the arterial 
wall characteristics back to a more favorable position on the non-
linear pressure-volume curve, reflected in a concomitant decrease in 
arterial pressure and improved aortic compliance. 
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Abstract 
LV systolic dysfunction in dialysis patients has been implicated in the 
genesis of dialysis hypotension. End-systolic elastance (Ees), a 
relatively load-independent parameter of myocardial contractility, was 
assessed by testing the acute left ventricular (LV) response to 
nitroglycerine (NTG) in hypotension-prone (HP) and hypotension-
resistant (HR) patients. 
Routine measurement of ejection fraction (EF) was done in fifteen 
patients before dialysis. Continuous arterial pressure was measured 
by Finapres as surrogate for LV pressure. LV area was measured 
using automated border detection as surrogate for LV volume. Systolic 
blood pressure (SBP) and LV area data were combined on-line to 
create pressure-area loops in real time following intravenous NTG 
bolus. Ees was determined off-line by beat-to-beat analysis of 
consecutive pressure-area loops. 
SBP, at baseline 168 mmHg (128-188 mmHg), decreased to 127 
mmHg (79-161 mmHg). End-systolic LV area, at baseline 6 cm2 (1-12 
cm2), decreased to 4 cm2 (1-10 cm2). Ees in the HP group (11 
mmHg.cm-2; 7-22 mmHg.cm-2) was not different from Ees in the HR 
group (9 mmHg.cm-2; 4-16 mmHg.cm-2). EF was 61% (45-73%). There 
was no correlation between Ees and EF. 
HP and HR patients had similar Ees. Thus, it seems doubtful whether 
LV systolic function plays an important role in the genesis of 
intradialytic hypotension. Ees in both groups was low compared to Ees 
from pressure-area loops in non-uremic patients undergoing cardiac 
surgery. As EF before dialysis indicated normal systolic function, LV 
systolic dysfunction in dialysis patients is masked by the load 
dependence of conventional measurements.  
 
Introduction 
The pathogenesis of intradialytic hypotension, a major complication of 
hemodialysis, has not been fully elucidated and is believed to be 
multifactorial, involving both dialysis-related and patient-related 
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factors [1]. Left ventricular (LV) systolic dysfunction, or reduced 
myocardial contractility, may lead to an inability to generate a 
sufficient cardiac output (CO) during a hemodynamic challenge such 
as the dialysis procedure. It is thought to contribute to an increased 
frequency of intradialytic hypotension [2,3]. However, accurate 
measurement of LV function in dialysis patients is hampered by the 
load dependence of commonly used parameters. Measurement of LV 
ejection fraction (EF) is widely used and generally accepted as 
parameter of LV systolic function [4], even though it does not 
accurately predict stroke volume (SV) and CO without consideration 
of the coexisting LV volumes (hence preload) and afterload [5]. EF 
reflects not only myocardial contractility but also cardiac filling and 
peripheral resistance, and therefore describes the entire 
cardiovascular system rather than the intrinsic properties of the 
myocardium [6]. The success of EF as a measure of LV systolic 
function in non-uremic patients is probably derived from the 
observation that, when myocardial contractility is reduced, SV is 
maintained at an increased preload, leading to a reduced EF. In 
hemodialysis patients, however, the cyclic changes in volume status, 
resulting from progressive volume overload before dialysis and volume 
withdrawal during dialysis, are associated with substantial changes in 
preload and afterload. In volume overload before HD, LV end-diastolic 
volume (EDV) may be increased, and peripheral resistance may be 
decreased. Although these changing loading conditions clearly affect 
routine LV function parameters, their relative contributions to the 
outcome of LV function measurements are difficult to determine. 
Newer Doppler echocardiography applications, such as mitral 
annulus velocity by Doppler tissue imaging, have been advocated as 
less load-dependent measures of LV systolic and diastolic function. 
However, these were recently shown to be load-dependent as well 
[7,8]. 
A more accurate assessment of LV systolic function can be obtained 
with simultaneous information on LV pressure and LV volume. This 
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can be used to establish the LV pressure-volume relationships or 
elastance E (∆P/∆V) throughout the cardiac cycle to measure the 
changes in myocardial contractility [9,10]. The end-systolic pressure-
volume relationship represents the mechanical properties of a fully 
contracted ventricle. End-systolic elastance (Ees) is an inherent 
characteristic of a given LV, and is a parameter of LV systolic function 
which is almost insensitive to changes in preload and afterload [10]. 
In a diagram showing pressure-volume measurements of consecutive 
cardiac cycles during a change in load, the end-systolic pressure- 
volume relationship is linear and thus represented by a straight line. 
The slope of this line represents Ees (Figure 1). A decreasing Ees value 
within the same patient over time, therefore, indicates deterioration of 
LV systolic function. The end-systolic pressure-volume relationship is 
 
 
Figure 1: Pressure-volume loop diagram of left ventricular (LV) contraction: 
normal situation and reduced end-systolic elastance (Ees) in LV 
systolic dysfunction. 
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not fixed for a given LV, and shifts with changes in contractile state of 
the myocardium, such as induced by the baroreflex. For determining 
Ees from LV pressure and volume loops during a change in load, it is 
therefore a prerequisite that only data measured before the onset of 
adrenergic activation be used. 
The invasive character of intraventricular pressure and volume 
measurements and the need for load alterations has limited the 
clinical application of Ees. The aim of this study was to measure Ees 
non-invasively in order to compare LV systolic function in 
hypotension-prone (HP) and hypotension-resistant (HR) dialysis 
patients, independent of their volume status. To this end, the LV 
response to acute preload reduction, induced by an intravenous bolus 
of nitroglycerine (NTG), was estimated from surrogate parameters for 
LV pressure and LV volume.  
 
Methods 
Study population  
Sixteen dialysis patients were enrolled in the study. None of these 
patients had symptomatic ischemic heart disease, significant (>+1) 
valvular disease or congestive heart failure. In one patient, the 
echocardiographic view was inadequate. Therefore, the results of the 
remaining 15 patients (median age 52 years, range 35 to 74 years) are 
reported.  
All patients were dialyzed following a standard dialysis prescription 
with ultrafiltration (UF), which had remained unchanged for three 
months. Dry weight was considered optimal when patients remained 
without symptoms of dyspnea, orthopnea or edema during the 
interdialytic period. None of the patients had symptoms or signs of 
volume overload. Hypotension was defined as a drop in systolic blood 
pressure of ≥ 25% or below 100 mmHg. A patient was defined as HP if 
intradialytic hypotension occurred in at least one third of dialysis 
sessions during the three months prior to the measurements, 
combined with symptoms of hypotension, such as dizziness and 
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nausea. The other dialysis patients, who did not meet these criteria, 
were defined as HR. Using these definitions, the study population 
consisted of 7 HP and 8 HR patients. The study was approved by the 
ethical review committee of our hospital. Written informed consent 
was obtained from all patients. 
 
Measurements  
All patients were tested shortly before the start of the dialysis 
procedure. The patients were in supine position, and were connected to 
the dialysis machine with only blood flow but no hemodialysis or UF 
taking place. Transthoracic echocardiograms were obtained using a 
Hewlett-Packard Sonos 5500 machine equipped with a 3.5 MHz 
transducer (Hewlett Packard, Andover, MA). An experienced 
echocardiographer performed all measurements. LV mass was 
measured from Penn Convention measurements according to Devereux 
and Reichek [11]. LV mass is reported as LV mass index (LVMI) by 
height according to the Framingham Study [12]. SV and EF were 
measured from the apical four chamber view using the Method of Discs 
single plane volume calculation (modified Simpson’s rule). Automated 
border detection was used to measure the changes in LV cavity area. 
Cross-sectional images were recorded from the midventricular short-
axis view, with the midpapillary muscle level as an anatomic landmark, 
and with the transducer positioned to obtain the image with the most 
circular area with uniform wall thickness. Echocardiographic gain 
settings were adjusted using visual assessment of the automated 
border. A region of interest was manually drawn beyond the LV 
endocardial border to exclude the right ventricular cavity. The area of 
pixels within this region identified as blood density was calculated from 
each frame and displayed as a waveform in real time. After adjusting 
the ordinate from the default volume setting (in ml) to area setting (in 
cm2), the changes in end-systolic LV cavity area were measured as a 
surrogate for LV volume. Continuous finger arterial blood pressure was 
recorded by Finapres (Ohmeda 2300 Finapres Blood Pressure 
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Monitor, Ohmeda, Louisville, CO). Systolic blood pressure (SBP) was 
used as a surrogate for end-systolic LV pressure.  
The analog echo and Finapres data were recorded using an analog to 
digital conversion system (ACODAS, DATAQ Instruments Inc, USA), 
which combined continuous SBP and LV area data on-line to create 
pressure-area loops in real time. Sampling and storage rate were 300 
Hz. The area signal was calibrated on both the echo machine and the 
computer workstation before the start of the measurements. Data 
were subsequently stored on a standard personal computer.  
 
Nitroglycerine administration 
To induce an acute decrease in preload, a bolus of nitroglycerine 
(NTG) was administered intravenously. Venous access was obtained 
by using the efferent (venous) line of the dialysis machine. NTG was 
administered through a three-way multiple infusion manifold placed 
immediately before the dialysis needle. Blood flow was set at 300 
ml/min.  The dosage of the initial bolus was at the discretion of the 
primary investigator, and was in the range of 0.1 to 0.5 mg. If 
tolerated well, a second bolus was given after 5 min. The dosage of the 
second bolus depended on the initial SBP decrease. If the initial 
decrease was < 20 mmHg, the dose was doubled.  If SBP decrease was 
≥ 20 mmHg and the patient agreed, the experiment was repeated 
using the same dose. 
 
Data analysis 
Ees was determined off-line by beat-to-beat analysis of consecutive 
pressure-area loops using a customized program written in in-house 
developed software (Matlab, The Mathworks Inc, USA), which was 
validated previously [13]. This analysis focused on the first series of 
pressure-area loops during SBP decline following the NTG bolus until 
the SBP nadir was reached or the heart rate increased by ≥ 10%, as a 
result of baroreflex activity. The end-systolic pressure-area relation 
was determined by an iterative search algorithm intended to maximize 
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the pressure-area ratio per beat. Subsequently, a linear regression 
was performed, and the slope of the regression line determined an 
initial Ees and area-axis intercept. The above mentioned analysis was 
repeated, now including an estimate of the area-axis intercept. This 
iterative process continued until convergence was reached for the 
area-axis intercept as described previously [14]. The slope of the last 
regression line was used for the determination of Ees.  
 
Statistical analysis 
Echocardiographic parameters and Ees in HP and HR patients were 
compared by the Mann-Whitney U-test. In patients with a second Ees 
measurement, the reproducibility was analyzed by the Wilcoxon 
matched pairs test. The correlation of Ees with EF was tested using 
the Spearman rank correlation coefficient. Data are reported as 
median values and range. In previous studies, data were reported as 
mean values. To compare those data to our results, we also report our 
data as mean values with standard deviation and used an unpaired t-
test. A p-value of less than 0.05 was considered to indicate statistical 
significance. 
 
Results 
Baseline measurements  
Echocardiography at baseline showed absence of significant valvular 
disease and wall motion abnormalities. All patients were in sinus 
rhythm. Measurements in the HP group: LVMI 169 g/m (93-264 g/m); 
end-diastolic volume 84 ml (50-140 ml); end-systolic volume 32 ml 
(19-65ml); SV 58 ml (31-85 ml); CO 3.9 L/min (2.8-6.1 L/min); EF 
61% (52-70%). Measurements in the HR group: LVMI 146 g/m (78-
247 g/m); end-diastolic volume 94 ml (74-148 ml); end-systolic 
volume 33 ml (25-82ml); SV 62 ml (42-93 ml); CO 4.4 L/min (2.5-5.5 
L/min); EF 63% (45-73%). None of these echo parameters was 
different in the two groups (Table 1).  
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Table 1: Echocardiographic parameters and end-systolic elastance in 
hypotension-prone and hypotension-resistant patients shortly before 
hemodialysis. 
 
 
Patients LVMI ESV SV EF Ees Ees (2nd) 
 g/m ml ml % mmHg.cm-2 mmHg.cm-2 
HP       
1 93 19 31 61 7  
2 174 65 70 52 22  
3 183 32 52 62 12 14 
4 169 30 58 65 11  
5 264 55 85 61 14 14 
6 141 35 49 61 8  
7 147 26 58 70 11 13 
Median 169 32 58 61 11  
HR       
8 78 33 52 61 11  
9 247 53 93 64 9  
10 173 82 66 45 8  
11 238 25 68 73 16 16 
12 116 30 65 69 9 8 
13 148 32 42 56 8  
14 144 47 53 53 4 3 
15 110 25 58 70 11 10 
Median 146 33 62 63 9  
p NS NS NS NS NS  
 
LVMI = left ventricular mass index; ESV = end-systolic volume; SV = stroke volume; 
EF = ejection fraction; Ees = end-systolic elastance; Ees(2nd)  = second Ees 
measurement in a subset; HP = hypotension-prone group; HR = hypotension-
resistant group; NS: None of the parameters were significantly different in the two 
groups. 
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Figure 2: Simultaneous decline of systolic peak pressure by Finapres and end-
systolic left ventricular (LV) cavity area following intravenous 
nitroglycerine bolus.  
 
 
 
 
 
Blood pressure response after NTG  
In all 15 patients, adequate Finapres signals were obtained 
throughout the duration of the experiment. After administration of the 
NTG bolus, a drop in blood pressure was observed within 30 seconds 
that lasted one minute maximally. The NTG bolus was generally 
tolerated well. Six patients complained of a mild transient headache. 
The other patients had no complaints apart from a transient 
hyperemia. SBP decline was > 20 mmHg after the initial NTG bolus in 
10 patients (Figure 2). Seven of these 10 patients agreed to repeat the 
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experiment and a second bolus with the same dose was given. There 
was an adequate decline in all other patients after a subsequent NTG 
bolus with a doubled dose. SBP at baseline was 168 mmHg (128-188 
mmHg) and decreased to 127 mmHg (79-161 mmHg). Diastolic BP at 
baseline was 87 mmHg (69-108 mmHg) and decreased to 71 mmHg 
(53-104 mmHg).  
 
LV area response to NTG 
End-systolic LV area at baseline was 6 cm2 (1-12 cm2) and decreased 
to 4 cm2 (1-10 cm2). End-diastolic LV area at baseline was 11 cm2 (7-
18 cm2) and decreased to 10 cm2 (6-16 cm2).  
 
Determination of Ees 
There were no ectopic beats recorded during the cardiac cycles used 
for determination of Ees. Ees was determined off-line by beat-to-beat 
analysis of consecutive pressure-area loops (Figure 3). Ees in the HP 
group (11 mmHg.cm-2; 7-22 mmHg.cm-2) was not different from Ees in 
the HR group (9 mmHg.cm-2; 4-16 mmHg.cm-2) (Table 1). In the 
subset of 7 patients in whom the experiment was repeated, the two 
Ees measurements showed good reproducibility: 11 mmHg.cm-2 (4-16) 
mmHg.cm-2 vs. 13 mmHg.cm-2 (3-16) mmHg.cm-2 (NS). There was no 
correlation between Ees and EF.  
 
Comparison to other studies 
To compare the results of the present study to those of other studies, 
we report the data for this dialysis population as mean values with 
standard deviation in Table 2. At baseline, end-systolic volume was 39 
± 18 ml, SV was 60 ± 16 ml, and EF was 62 ± 89 %. Ees was 11 ± 4  
mmHg.cm-2. SV in our study did not differ from SV values in previous 
studies. However, Ees in our study was lower, and significantly so 
compared to two of the three populations in the previous studies. 
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Figure 3: Time-varying elastance (E(t)) and determination of end-systolic 
elastance (Ees) by beat-to-beat analysis of consecutive pressure-area 
loops. 
 
 
 
Table 2: Comparison of left ventricular systolic function parameters in 
hemodialysis patients and in patients before and after coronary artery 
bypass graft. 
 
Population n SV EF Ees 
  ml % mmHg.cm-2 
HD (present study) 15 60 ± 16 62 ± 8 11 ± 4 
Pre CABG [15] 7 62 ± 30 53 ± 12 32 ±  12* 
Post CABG [15] 7 55 ± 17 NR 15 ±  6 
Post CABG [16] 23 54 ± 22 NR 26 ± 12* 
 
 
HD = hemodialysis patients; Pre/Post CABG = patients before/after coronary artery 
bypass graft operation [15, 16]; SV = stroke volume; EF = ejection fraction; NR = not 
reported; Ees = end-systolic elastance calculated from pressure-area data; * Ees 
significantly different from value in present study (p<0.0001). 
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Discussion 
This is the first study to assess Ees non-invasively in a dialysis 
population, as relatively load-independent measure of LV systolic 
function. These dialysis patients had a normal LV systolic function as 
measured by EF. Ees, estimated from pressure-area loops, was low 
compared to Ees values in previous studies [15,16], in which pressure-
area loops were measured in patients before and after undergoing 
coronary bypass surgery (CABG). There was no difference in LV 
systolic function, as measured by Ees, between the HP and the HR 
dialysis patients. 
The study by Gorcsan et al. demonstrated a decrease in Ees 
immediately following CABG, whereas load-dependent measures of LV 
systolic function, such as SV and CO, were unchanged in the same 
patients. The authors postulated several factors causing this decrease 
in LV systolic function, including hypothermia, ischemia, reperfusion, 
oxygen-derived free radicals and inflammatory mediators. In our 
study, Ees was low even compared to post CABG values. The low Ees in 
these dialysis patients indicated poor LV systolic function compared 
to patients who were non-uremic, but did have coronary artery 
disease.  
However, there was no correlation between Ees and EF, and despite 
low Ees values, EF measurement appeared to indicate good systolic 
function in these patients. This may be explained by the timing of the 
measurements shortly before dialysis with UF. Volume loading has 
repeatedly been shown to increase EF, primarily due to a decrease in 
total peripheral resistance with a concomitant decrease in end-
systolic volume [17]. Although none of the patients had symptoms of 
overt hypervolemia, they were in a state of relative fluid overload. By 
measuring Ees non-invasively in a dialysis population, we have 
assessed LV systolic function independent of volume status. While Ees 
measurement has been developed in animals, and has been applied 
clinically in several patient populations, it has never been applied in 
dialysis patients. Ees measurement indicated the presence of LV 
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systolic dysfunction in this dialysis population, which was masked 
due to the load dependence of EF. 
LV systolic dysfunction may lead to congestive heart failure, although 
in dialysis patients, it is difficult to distinguish between extracellular 
volume overload before dialysis or congestive heart failure reflecting 
LV dysfunction [18]. During hypovolemia, however, the role of 
myocardial contractility as a cardiac compensatory mechanism is 
open to question [19].  Does a reduced myocardial contractility affect 
the hemodynamic response to volume withdrawal, and could it 
therefore play an important role in the pathogenesis of intradialytic 
hypotension? Studies in animals and humans have shown that in 
hypovolemia, cardiac compensation mechanisms, i.e. increased 
contractility and heart rate resulting from sympathetic activation, play 
a limited role. BP response was not altered under pharmacological ß-
adrenergic blockade or by cardiac denervation [1]. It is clear that in 
the genesis of intradialytic hypotension, the most important initiating 
factor is the decrease in blood volume, which is inherent to the 
dialysis procedure [20]. According to Starling’s Law of the Heart, “the 
output of the heart is … determined by the amount of blood flowing 
into the heart” [21]. Therefore, in hypovolemia, when venous return 
declines, the reduction in cardiac filling determines CO. Optimizing 
pump function has hardly any effect if cardiac filling is decreased to 
the point that SV is too low for an adequate CO. If LV systolic function 
does not determine CO during reduced cardiac filling, it seems 
doubtful whether systolic dysfunction predisposes to intradialytic 
hypotension. This is confirmed by our finding that Ees in HP dialysis 
patients was not different from Ees in HR patients. 
The need for load alterations, such as achieved by inferior vena cava 
occlusion in previous studies [15, 16], has been a limitation to the 
clinical application of Ees measurements. An intravenous NTG bolus is 
a simple method to induce an acute decrease in preload in a dialysis 
patient connected to a dialysis machine. As a result of the large blood 
flow in an arteriovenous shunt, the effect of a NTG bolus is quick in 
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onset and short in duration. It was generally tolerated well, as 
patients are relatively protected from an excessive decline in blood 
pressure by their hypervolemic state before dialysis. Although it would 
be interesting to repeat these Ees measurements after dialysis to test 
the effect of the dialysis procedure on LV systolic function, 
administration of NTG at the end of dialysis carries an increased risk 
of inducing symptomatic hypotension.  
To circumvent the need for load alteration, an alternative approach is 
to estimate Ees on a single-beat basis [22,23]. However, these methods 
rely on several assumptions and result in more variation in Ees 
estimates than with the method based on preload-varied beat-to-beat 
analysis [24]. This is partly due to the use of additional information 
from other time-points in the single pressure-volume loop, which 
reintroduces load-dependent elements.  
Although clinically feasible and well tolerated, a non-invasive 
approach means the use of surrogate markers for LV pressure and 
volume. This is an inherent limitation to our study. Automated border 
detection has been used before to record changes in LV cavity area as 
a result of preload variation. Cross-sectional images of LV cavity 
changes recorded from the midventricular short-axis view, with the 
midpapillary muscle level as an anatomic landmark, have been shown 
to closely correlate with changes in LV volume [14,15,25]. In those 
studies, automated border detection was used with transesophageal 
echocardiography in unconscious patients in the operation room. 
Transthoracic echocardiography is a non-invasive alternative in a 
conscious dialysis patient in a dialysis room, which yields good 
quality LV cross-sectional images in the midventricular short-axis 
plane in selected patients. 
To measure arterial pressure continuously and non-invasively, 
Finapres SBP was used as a surrogate for LV end-systolic pressure, 
which has not been done before in pressure-area relation 
measurements. Finger pressure measurement with Finapres is an 
accepted method to measure blood pressure continuously, and 
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Finapres SBP readings agree well with intra-arterial SBP 
measurements [26]. A possible limitation of this technique is the 
distance traveled by the pressure wave. Dialysis patients may have 
arteriosclerosis, leading to an increased pressure gradient. This may 
interfere with the Finapres measurements, although in the present 
study all patients had excellent arterial wave recordings. However, for 
the calculation of Ees, we were not interested in the absolute pressure 
values, but only in pressure changes. Changes in peripheral peak 
pressure, measured invasively in the femoral and brachial artery or as 
SBP by sphygmomanometry, have been shown to correlate with 
changes in LV end-systolic pressure, provided that there is no 
significant aortic stenosis or any other LV outflow tract obstruction 
present [9,27]. 
We conclude that, as the HP and HR groups in this study had a 
similar Ees, these two types of dialysis patients are not distinguished 
by a difference in myocardial contractility. Thus, it seems doubtful 
whether LV systolic dysfunction plays an important role in the genesis 
of intradialytic hypotension. Ees in both groups was low compared to 
Ees from pressure-area loops in non-uremic patients undergoing 
cardiac surgery. As EF before dialysis indicated normal systolic 
function, LV systolic dysfunction in dialysis patients is masked by the 
load dependence of conventional measurements.  
 
 
 
 
 
 
 
 
 
 
 
 Systolic Dysfunction and Dialysis Hypotension 
 135
References 
 
1. Daugirdas JT: Dialysis hypotension: a hemodynamic analysis. Kidney Int 
1991;39:233-246 
 
2. Henrich WL (editor): Principles and practice of dialysis, 3rd ed., Philadelphia, 
Lippincott Williams and Wilkins, 2004, p 284 
 
3. Rubinger D, Revis N, Pollak A, et al: Predictors of haemodynamic instability 
and heart rate variability during hemodialysis. Nephrol Dial Transplant 
2004;19: 2053-2060 
 
4. Gandhi SK, Powers JC, Nomeir AM, et al: The pathogenesis of acute 
pulmonary edema associated with hypertension. N Engl J Med 2001;344:17-
22 
 
5. Andrew P: Diastolic heart failure demystified. Chest 2003;124:744-753 
 
6. Robotham JL, Takata M, Berman M, Harasawa Y: Ejection fraction revisited. 
Anesthesiology 1991;74:172-183 
 
7. Ama R, Segers P, Roosens C, et al: The effects of load on systolic mitral 
annular velocity by tissue Doppler imaging. Anesth Analg 2004;99:332-338 
 
8. Ie EH, Vletter WB, ten Cate FJ, et al: Preload dependence of new Doppler 
techniques limits their utility for left ventricular diastolic function 
assessment in hemodialysis patients. J Am Soc Nephrol 2003;14:1858-1862 
 
9. Sagawa K, Maughan L, Suga H, Sunagawa K: Cardiac contraction and the 
pressure-volume relationship, New York, Oxford University Press, 1988, pp 
3-7 
 
10. Zipes DP, Libby P, Bonow RO, Braunwald E (editors): Braunwald’s heart 
disease. A textbook of cardiovascular medicine, 7th ed., Philadelphia, Elsevier 
Saunders, 2005, pp 492-496 
 
11. Devereux RB, Reichek N: Echocardiographic determination of left ventricular 
mass in man. Circulation 1977;55:613-618 
 
Chapter 7 
 136 
12. Levy D, Savage DD, Garrison RJ, et al: Echocardiographic criteria for left 
ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 
1987;59:956-960 
 
13. Krams R, Duncker DJ, McFalls EO, et al: Dobutamine restores the reduced 
efficiency of energy transfer from total mechanical work to external 
mechanical work in stunned porcine myocardium. Cardiovasc Res 
1993;27:740-747 
 
14. Gorcsan J, Romand JA, Mandarino WA, et al: Assessment of left ventricular 
performance by on-line pressure-area relations using echocardiographic 
automated border detection. J Am Coll Cardiol 1994;23:242-252 
 
15. Gorcsan J, Gasior TA, Mandarino WA, et al: Assessment of the immediate 
effects of cardiopulmonary bypass on left ventricular performance by on-line 
pressure-area relations. Circulation 1994;89:180-190 
 
16. Declerck C, Hillel Z, Shih H, et al: A comparison of left ventricular 
performance indices measured by transesophageal echocardiography with 
automated border detection. Anesthesiology 1998;89:341-349 
 
17. Kumar A, Anel R, Bunnell E, et al: Effect of large volume infusion on left 
ventricular volumes, performance and contractility parameters in normal 
volunteers. Intensive Care Med 2004;30:1361-1369 
 
18. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in 
chronic renal disease. J Am Soc Nephrol 1998;9:S16-23 
 
19. Daugirdas JT: Pathophysiology of dialysis hypotension: an update. Am J 
Kidney Dis 2001;38(Suppl 4): S11-S17 
 
20. Koomans HA: Body fluid dynamics during dialysis and in dialysis 
hypotension. Contrib Nephrol 1996;119:173-181 
 
21. Katz AM: Ernest Henry Starling, his predecessors, and the “Law of the 
Heart”. Circulation 2002;106:2986-2992 
 
 Systolic Dysfunction and Dialysis Hypotension 
 137
22. Takeuchi M, Igarashi Y, Tonimoto S, et al: Single-beat estimation of the slope 
of the end-systolic pressure-volume relation in the human left ventricle. 
Circulation 1991;83:202-212 
 
23. ShishidoT, Hayanshi K, Shigemi K, et al: Single-beat estimation of end-
systolic elastance using bilinearly approximated time-varying elastance 
curve. Circulation 2000;102:1983-1989 
 
24. Kjörstad KE, Korvald C, Myrmel T: Pressure-volume-based single-beat 
estimations cannot predict left ventricular contractility in vivo. Am J Physiol 
2002;282:H1739-750 
 
25. Appleyard RF, Glantz SA : Two dimensions describe left ventricular volume 
change during hemodynamic transients. Am J Physiol 1990;258:H277-284 
 
26. Parati G, Casadei R, Groppelli A, et al: Comparison of finger and intra-
arterial blood pressure monitoring at rest and during laboratory testing. 
Hypertension 1989;13:647-655 
 
27. Gorcsan J, Denault A, Gasior TA, et al: Rapid estimation of left ventricular 
contractility from end-systolic relations by echocardiographic automated 
border detection and femoral arterial pressure. Anesthesiology 1994;81:553-
562 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  138 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 139
CHAPTER 8:  
 
Summary and Conclusions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Chapter 8 
 140 
Summary and conclusions 
 
Chapter 1 is a brief introduction to several aspects of cardiovascular 
pressure-volume relations in dialysis patients. The aims of the thesis 
are presented. 
  
In Chapter 2, an overview is presented of circulatory physiology in 
hemodialysis (HD) patients. Volume withdrawal by ultrafiltration 
during HD may lead to intravascular hypovolemia and intradialytic 
hypotension. Hemodynamic defense mechanisms are discussed, 
focusing on left ventricular (LV) function. The concept of load, which 
reflects the interaction between the heart and the vascular system, is 
explained.  
Chronic pressure and volume overload account for a high prevalence 
of left ventricular hypertrophy (LVH) in dialysis patients. LVH may 
lead to LV dysfunction, which may eventually become manifest as 
heart failure. In dialysis patients, however, elevated cardiac filling 
pressures may reflect volume overload before HD rather than heart 
failure, and loading conditions are altered by volume witdrawal 
during HD.  
The cyclic changes in volume status hamper the assessment of LV 
function in HD patients. Current LV systolic and diastolic function 
measurements in clinical practice are reviewed. The load dependence 
of these measurements is discussed. Finally, future perspectives for 
load-independent assessment of LV function and measurement of 
pressure-volume relations in clinical dialysis practice are suggested. 
 
The cyclic changes in volume status and recurring cardiovascular 
strains of the HD procedure may lead to chronic myocardial damage, 
especially in patients with LVH or myocardial fibrosis. In these 
conditions, a decreased myocardial capillary density and reduction in 
myocardial flow reserve may lead to a reduced myocardial perfusion 
pressure during HD or volume overload before HD. In Chapter 3, we 
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observed a high incidence of elevated cardiac troponin T (cTnT) 
measured in our entire dialysis population before a HD session. 
Although none of the patients had evidence of acute ischemic 
myocardial injury, baseline cTnT was elevated in 82%. The incidence 
of elevated cTnT was higher in patients with a history of 
cardiovascular disease. During a two-year follow-up period, patients 
with an elevated cTnT also had a higher mortality rate.  
In a subgroup, cTnT was measured during the HD procedure and no 
change in cTnT levels was found. We concluded that elevated cTnT 
levels in asymptomatic dialysis patients are of prognostic value. They 
are not caused by acute myocardial injury or by HD itself, but may be 
related to chronic myocardial damage or decreased clearance of cTnT 
degradation fragments.  
However, in dialysis patients who had an acute coronary syndrome 
during the follow-up period, cTnT increased above baseline, and 
tended to return to baseline after recovery. Therefore, a cTnT rise in 
dialysis patients above the individual baseline does appear to be 
diagnostic of acute myocardial injury. 
 
LV diastolic dysfunction is believed to be common in dialysis patients, 
especially in patients with LVH. However, as conventional echo 
Doppler parameters are load-dependent, predialysis hypervolemia 
may lead to pseudonormalization, and thereby mask diastolic 
dysfunction.  
In Chapter 4, we introduced new Doppler parameters of LV diastolic 
function. Mitral annulus velocity by Doppler tissue imaging (DTI) and 
LV inflow propagation velocity from color M-mode were measured 
before and after HD. Using these new echo Doppler techniques, which 
have been proposed as relatively preload-independent measurements 
of diastolic function, we demonstrated diastolic dysfunction in this 
study population.  
Unexpectedly, these techniques exhibited a pattern of load 
dependence similar to that displayed by the conventional Doppler 
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measurements. So even when using the newer Doppler techniques, 
the degree of diastolic dysfunction was underestimated as a result of 
pseudonormalization due to volume overload. Therefore, the 
advantage of these techniques over conventional parameters for the 
assessment of LV diastolic function in dialysis patients is limited. 
 
Alternatively, DTI may reflect the actual diastolic function, which 
would imply that HD impaired cardiac relaxation and thereby 
worsened LV diastolic function. This could have been caused by the 
increase in serum ionized calcium concentration during HD.  
To further unravel the effects of changes in volume and in serum 
ionized calcium, we tested the effect of HD without ultrafiltration on 
these measurements, as was described in Chapter 5. Transmitral flow 
and mitral annulus velocities were measured before and after 1 hour 
of HD without ultrafiltration.  
The use of a standard 1.75 mmol/L dialysate Ca2+ concentration 
resulted in a significant increase in serum ionized calcium after one 
hour. Despite this increase, there was no change in transmitral flow 
and tissue Doppler velocities. This confirms the conclusion of the 
previous chapter, i.e. that the change in both transmitral Doppler and 
DTI results from changes in preload. 
 
Chronic pressure overload results from increased arterial stiffness, 
which becomes clinically manifest as systolic hypertension with an 
increased pulse pressure. A reduced aortic compliance signifies an 
increased cardiac pulsatile load, which promotes the development of 
LVH.  
In Chapter 6, a pulse pressure method is introduced, which is based 
on the Windkessel model, and can be used to estimate aortic 
compliance non-invasively. This technique, which combines carotid 
pulse contour analysis by applanation tonometry with aortic outflow 
volume measurements by Doppler echocardiography, has not been 
applied before in a dialysis population.  
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We tested whether a reduction in volume overload by ultrafiltration 
during HD leads to an improvement of aortic compliance. After 
volume withdrawal, we observed a concomitant decrease in arterial 
pressure and a small improvement in aortic compliance.  
We concluded that the increase in aortic stiffness in dialysis patients 
is partly caused by a reversible reduction of aortic compliance due to 
volume expansion. Volume withdrawal by HD moves the arterial wall 
characteristics back to a more favorable position on the non-linear 
pressure-volume curve. 
 
LV systolic dysfunction is thought to contribute to an increased 
frequency of intradialytic hypotension. However, accurate 
measurement of LV function in dialysis patients is hampered by the 
load dependence of commonly used parameters, such as the LV 
ejection fraction (EF).  
The end-systolic pressure-volume relationship, or end-systolic 
elastance (Ees), represents the mechanical properties of a fully 
contracted ventricle. This inherent characteristic of a given LV is a 
parameter of LV systolic function which is almost insensitive to load. 
Ees was estimated non-invasively in hypotension-prone and 
hypotension-resistant dialysis patients from the acute LV response to 
preload reduction by nitroglycerine, as described in Chapter 7.  
EF, LV area and finger arterial pressure (Finapres) were recorded 
continuously before HD. Finapres and LV area data were combined to 
create pressure-area loops following intravenous nitroglycerine. 
Hypotension-prone and hypotension-resistant dialysis patients had 
similar Ees. Thus, it seems doubtful whether LV systolic function 
plays an important role in the genesis of intradialytic hypotension.  
Ees in both groups was low compared to Ees from pressure-area loops 
in non-uremic patients undergoing cardiac surgery. As EF before 
dialysis indicated normal systolic function, LV systolic dysfunction in 
dialysis patients is masked by the load dependence of conventional 
measurements. 
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The measurement of LV pressure-volume relations yields valuable 
information on how the LV is coupled to the vascular system. This 
knowledge is essential in identifying dialysis patients with LV 
dysfunction. With this information, dialysis patients with heart failure 
can be distinguished from dialysis patients with excessive volume 
overload before HD, in whom lowering dry weight might suffice. 
Identification of dialysis patients with LV dysfunction at an earlier 
stage, i.e. before heart failure becomes clinically manifest, not only 
helps secondary prevention, but also provides a tool for measuring 
the results of treatment and intervention trials. Clinically applicable, 
load-independent measurement of LV function, therefore, could help 
improve the quality of life and management of our dialysis patients. 
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Samenvatting en conclusies 
 
Hoofdstuk 1 is een korte inleiding waarin verschillende aspecten van 
cardiovasculaire druk-volumerelaties in hemodialysepatiënten en de 
doelstellingen van het proefschrift worden gepresenteerd. 
 
In Hoofdstuk 2 wordt een overzicht gepresenteerd van de fysiologie 
van de circulatie in hemodialysepatiënten. Het onttrekken van volume 
door middel van ultrafiltratie tijdens hemodialyse kan leiden tot 
intravasculaire ondervulling en intradialytische hypotensie. 
Hemodynamische verdedigingsmechanismen worden besproken, 
waarbij de nadruk ligt op de functie van de linker ventrikel (LV) van 
het hart. Het begrip load, waarmee de interactie tussen het hart en 
het vaatstelsel wordt weergegeven, wordt uitgelegd.  
Chronische druk- en volumeoverbelasting zijn verantwoordelijk voor 
een hoge prevalentie van linkerventrikelhypertrofie (LVH) in 
dialysepatiënten. LVH kan leiden tot LV dysfunctie, hetgeen manifest 
kan worden als hartfalen. In dialysepatiënten kan een verhoogde 
cardiale vullingsdruk echter een uiting zijn van hypervolemie 
voorafgaande aan de hemodialyse in plaats van hartfalen. Verder 
worden preload en afterload beïnvloed door het onttrekken van 
volume door ultrafiltratie tijdens de dialyse.  
De cyclische veranderingen van de volumetoestand kunnen een 
belemmering vormen voor het onderzoek van de LV functie in 
dialysepatiënten. De momenteel gangbare methoden om de 
systolische en diastolische LV functie in de klinische praktijk te meten 
worden besproken, alsmede hun load-afhankelijkheid. Ten slotte 
worden er suggesties gedaan om de LV functie en druk-volumerelaties 
onafhankelijk van de load te meten. 
 
De cyclische veranderingen in volumestatus en steeds wederkerende 
cardiovasculaire belasting van de dialyseprocedure kunnen leiden tot 
chronische schade aan het myocard, in het bijzonder bij patiënten 
                              Samenvatting en Conclusies  
 151
met LVH of myocardfibrose. Bij de laatstgenoemde aandoeningen 
bestaat er veelal een lagere capillaire dichtheid en verminderde 
capillaire flow reserve, hetgeen kan leiden tot een verlaagde 
perfusiedruk van het myocard tijdens de hemodialyse of tijdens 
overvulling voorafgaande aan de hemodialyse.  
In Hoofdstuk 3 observeerden wij een hoge incidentie van verhoogd 
cardiaal troponine T (cTnT) gemeten in onze gehele dialysepopulatie 
kort voor de start van een dialysesessie. Alhoewel er bij geen der 
patiënten aanwijzingen waren voor acute ischemische 
myocardschade, was het cTnT verhoogd in 82%. De incidentie van 
verhoogd cTnT was hoger in patiënten met een voorgeschiedenis van 
cardiovasculaire morbiditeit. Tijdens een follow-up periode van twee 
jaar was er onder patiënten met een verhoogd cTnT tevens een hogere 
mortaliteit.  
cTnT werd in een subgroep ook gemeten tijdens de dialyseprocedure: 
er werd geen verandering van cTnT-concentraties gemeten. Wij 
concludeerden dat verhoogde plasma-cTnT-concentraties in 
asymptomatische dialysepatiënten een prognostische waarde hebben. 
De verhoging van deze concentraties wordt niet veroorzaakt door 
acute myocardschade of door de dialyseprocedure zelf, maar zou een 
gevolg kunnen zijn van chronische myocardschade of een 
verminderde klaring van cTnT-afbraakproducten.  
Echter, in dialysepatiënten die tijdens de follow-up periode 
daadwerkelijk een acuut coronair syndroom doormaakten, steeg het 
cTnT ten opzichte van bovengenoemde uitgangswaarde. Na herstel 
daalde het cTnT wederom richting het niveau van deze 
uitgangswaarde. Daarom lijkt bij dialysepatiënten een stijging van het 
cTnT boven het niveau van de individuele basislijn wel degelijk bij te 
dragen aan de diagnose van acute myocardschade.  
 
Diastolische dysfunctie van de LV lijkt veel voor te komen bij 
dialysepatiënten, speciaal bij patiënten met LVH. De in de kliniek veel 
gebruikte echo Doppler-parameters zijn evenwel load-afhankelijk, 
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waardoor hypervolemie voor de hemodialyse kan leiden tot 
pseudonormalisatie en maskering van diastolische dysfunctie.  
In Hoofdstuk 4 introduceerden wij nieuwe Doppler-parameters voor 
het meten van de diastolische functie. Mitral annulus velocity gemeten 
met Doppler tissue imaging (DTI) en LV inflow propagation velocity 
gemeten met color M-mode werden gemeten voor en na de 
hemodialyse. Door deze nieuwe echo Doppler-technieken, die 
beschouwd worden als relatief preload-onafhankelijke metingen van 
de diastolische functie, te gebruiken was het mogelijk om diastolische 
dysfunctie in deze studiepopulatie aan te tonen.  
Een onverwachte bevinding was echter dat deze technieken, net als de 
conventionele Doppler-metingen, een patroon van load-
afhankelijkheid vertoonden. Het gevolg hiervan was dat zelfs bij het 
gebruik van deze nieuwere Doppler-technieken de ernst van de 
diastolische dysfunctie werd onderschat als gevolg van 
pseudonormalisatie door hypervolemie. Daardoor is het voordeel van 
deze nieuwe technieken ten opzichte van de conventionele technieken 
voor het bepalen van de diastolische functie van de LV beperkt. 
 
Indien DTI alleen een afspiegeling is van de werkelijke diastolische 
functie, zou dat betekenen dat het dialyseproces zelf de relaxatie van 
de LV en daarmee de diastolische functie verslechterde. Dit zou 
veroorzaakt kunnen zijn door de stijging van de geïoniseerde 
calciumconcentratie van het serum tijdens de hemodialyse.  
Om de effecten van veranderingen in volume en in geïoniseerde 
calciumconcentratie van het serum verder uit elkaar te halen, hebben 
we het effect van dialyse zonder ultrafiltratie op deze metingen 
onderzocht, zoals beschreven in Hoofdstuk 5. Transmitraal flow 
velocities en mitral annulus velocities werden gemeten voorafgaande 
aan een dialysesessie en na 1 uur dialyse zonder ultrafiltratie.  
Het gebruik van standaarddialysaat met een Ca2+ concentratie van 
1.75 mmol/l resulteerde in een significante stijging van het 
geïoniseerde calcium in het serum na 1 uur. Ondanks deze stijging 
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was er geen verandering in transmitraal flow velocities en mitral 
annulus velocities. Dit is een bevestiging van de conclusie van het 
vorige hoofdstuk, namelijk dat de veranderingen van zowel 
transmitraal Doppler en DTI het gevolg zijn van veranderingen in 
preload. 
 
Chronische drukoverbelasting is het gevolg van verhoogde arteriële 
stijfheid, wat zich klinisch kan uiten als systolische hypertensie met 
een verhoogde pulse pressure. Een verminderde compliantie van de 
aorta betekent een toegenomen pulsatiele load voor het hart, wat het 
ontstaan van LVH bevordert.  
In Hoofdstuk 6 wordt een pulse pressure methode geïntroduceerd. 
Deze is gebaseerd op het model van de windketel en kan worden 
gebruikt om de compliantie van de aorta op non-invasieve wijze te 
schatten. Bij deze techniek wordt applanatietonometrie, waarmee de 
contour van de pulsgolf in de arteria carotis wordt geanalyseerd, 
gecombineerd met Doppler-echocardiografische metingen van het 
outflow volume in de aorta. De techniek is niet eerder toegepast in 
een dialysepopulatie. Hiermee werd onderzocht of een reductie van de 
volumeoverbelasting met behulp van ultrafiltratie tot een verbetering 
van de compliantie van de aorta leidt.  
Na het onttrekken van volume namen we een gelijktijdige daling in 
arteriële druk en een kleine verbetering van de compliantie van de 
aorta waar. Hieruit concludeerden wij dat de toegenomen stijfheid van 
de aorta bij dialysepatiënten gedeeltelijk wordt veroorzaakt door een 
reversibele afname van de compliantie van de aorta, die het gevolg is 
van volume-expansie. Door vocht te onttrekken tijdens de dialyse 
kunnen de arteriële vaatwandeigenschappen terug worden gebracht 
naar een gunstigere positie op de non-lineaire druk-volumecurve.  
 
Systolische dysfunctie van de LV wordt verondersteld bij te dragen 
aan een verhoogde kans op het ontstaan van dialysehypotensie. 
Accurate meting van de LV functie in dialysepatiënten wordt 
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gehinderd door de load-afhankelijkheid van de doorgaans gebruikte 
parameters, zoals de LV ejectiefractie (EF).  
De eindsystolische druk-volumerelatie – of eindsystolische elastantie 
(Ees) – vertegenwoordigt de mechanische eigenschappen van een 
volledig gecontraheerde ventrikel. Dit is een inherente eigenschap van 
een bepaalde LV en een systolische functieparameter die vrijwel 
ongevoelig is voor load. In Hoofdstuk 7 wordt beschreven hoe Ees werd 
geschat op non-invasieve wijze in dialysepatiënten die vaak een lage 
bloeddruk tijdens dialyse hebben (hypotension-prone, HP), en 
patiënten die dat niet vaak hebben (hypotension-resistant, HR).  
Dit gebeurde aan de hand van de acute respons van de LV op 
preload-verlaging door nitroglycerine. EF, het oppervlak van de 
dwarse doorsnede van de LV en Finapres (finger arterial pressure) 
werden continu gemeten gedurende een korte periode voorafgaande 
aan de hemodialyse. Data van Finapres en LV oppervlak werden 
gecombineerd om druk-oppervlaktediagrammen te creëren volgend op 
een intraveneuze bolus nitroglycerine.  
HP en HR dialysepatiënten hadden een zelfde Ees. Daarom lijkt het te 
betwijfelen of de systolische functie van de LV een belangrijke rol 
speelt in de pathogenese van dialysehypotensie. Ees in beide 
patiëntengroepen was laag vergeleken met Ees gemeten uit druk-
oppervlaktediagrammen in non-uremische patiënten die cardiale 
chirurgie ondergingen. Aangezien EF, zoals gemeten voorafgaande 
aan de hemodialyse, paste bij een normale systolische functie, blijkt 
hieruit dat systolische dysfunctie in dialysepatiënten wordt 
gemaskeerd door de load-afhankelijkheid van de conventionele 
metingen. 
 
De meting van de druk-volumerelaties van de LV levert waardevolle 
informatie over hoe de LV gekoppeld is aan het vaatstelsel. Het 
verkrijgen van deze informatie is essentieel voor het identificeren van 
dialysepatiënten met LV dysfunctie. Met deze informatie kunnen 
dialysepatiënten met hartfalen worden onderscheiden van 
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dialysepatiënten met overmatige overvulling voor de hemodialyse, bij 
wie het verlagen van het streefgewicht voldoende zou kunnen zijn.  
Het vroeg kunnen herkennen van dialysepatiënten met LV dysfunctie, 
dat wil zeggen voordat hartfalen klinisch manifest wordt, is niet alleen 
een vorm van secundaire preventie, maar is ook van belang om de 
resultaten van behandeling en interventiestudies te vervolgen. 
Daarom zou een klinisch toepasbare, load-onafhankelijke meting van 
de LV functie bij kunnen dragen aan verbetering van de kwaliteit van 
leven en de behandeling van onze dialysepatiënten.  
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Dankwoord 
 
Reizen heeft tot doel de onbekende wereld te verkennen maar ook om 
vanuit den vreemde terug te blikken op de bekende wereld van 
thuis… en van het werk. Dat werk heeft de afgelopen tijd in het teken 
gestaan van onderzoek, dat in deze periode wordt voltooid met een 
proefschrift. Vanuit het Finse winterlandschap is het daarom goed om 
terug te blikken en een woord van dank uit te spreken aan hen die 
een belangrijke rol hebben gespeeld bij dit werk. 
Mijn promotor: prof.dr. W. Weimar. Beste Willem, toen ik kwam 
praten over nefrologie-opleiding en onderzoek, schetste je de 
hoofdlijnen: T-cellen of hemodynamica. Mijn keuze voor het laatste 
heeft je er niet van weerhouden met een zeker kritisch enthousiasme 
de voortgang op de afdeling Hemodialyse te vervolgen. Dank dat je 
mijn promotor wilt zijn. 
Mijn copromotor: dr. R. Zietse. Beste Bob, jouw ongeëvenaarde gevoel 
voor humor houdt de stemming er goed in, ook al verloopt een 
onderzoek niet altijd naar wens van de promovendus. Ik heb veel van 
je geleerd. Je hebt ook mijn latinistische neigingen wat kunnen 
onderdrukken (punt). Twee korte zinnen zijn soms duidelijker dan één 
lange. Aan de andere kant is het ook zo, dat jij steeds enthousiaster 
geworden bent in het plaatsen van komma’s, om zodoende steeds 
langere zinnen, die zowel beperkende als uitbreidende bijzinnen 
bevatten, van enige structuur te voorzien, opdat ze tenminste nog 
enigszins leesbaar blijven. Wellicht gloort er in de toekomst ook voor 
jou een buste, bijvoorbeeld in de centrale hal van het nieuwe Erasmus 
MC! Vooralsnog hoop ik nog vele vruchten (fruits de mer) te mogen 
plukken van besprekingen onder het genot van een hors d’oeuvre Soit 
of een Tower of Power. 
“All echocardiographic measurements were performed by the same 
experienced echocardiographist”, zo valt te lezen in verschillende 
hoofdstukken. Dit was Wim Vletter. Beste Wim, het was een groot 
plezier om met je te werken. Nadat je kennis had gemaakt met de 
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wondere wereld van de Hemodialyse, was je een onverstoorbare peiler 
in ons onderzoek. Je ontdekte de Wet van Vletter (patiënten worden in 
de loop van het dialyseproces minder echogeniek). Je liet zien dat het, 
na mensen gevraagd te hebben “even niet meer te ademen”, niet nodig 
is te zeggen “u kunt weer doorademen” (dat doet men toch wel). Dank 
voor al je tijd en enthousiasme. 
Van niemand heb ik meer geleerd over de functie van het hart dan 
van Rob Krams. Beste Rob, als ik je dan eindelijk weer gevonden had 
daar boven ergens op de 22e of 23e verdieping, werd ik bijgeschoold 
over de kurkentrekkerbeweging van de contractie van de linker 
ventrikel of de vraag waar systole en diastole nou eigenlijk in elkaar 
overgaan. En ook al zeg je een geheugen als een zeef te hebben, je lijkt 
meer een verstrooide professor die al redenerend altijd weer de 
oplossing vindt. Ooit wordt je nog eens Rob Krams III! 
Graag wil ik ook de cardiologen Folkert ten Cate en Peter Klootwijk 
bedanken voor hun bijdrage aan enkele studies, waarin we 
onderzoekers in hart en nieren zijn geworden. 
Natuurlijk een woord van dank voor de Belgisch-Amerikaanse 
collega’s Tine DeBacker en Stéphane Carlier. Tine, ook al ging voor de 
metingen altijd een van je drie piepers af, dankzij je tomeloze energie 
kwam het goed. Overigens, Stéphane, de kwaliteit van 3D-echo’s van 
de baarmoeder is de afgelopen jaren wel wat verbeterd. 
Jan Tuin: jij mag je met recht “audiovisuele man” noemen. Toen ik je 
voor het eerst opzocht, had ik nooit het bestaan van het AV-walhalla 
achter de deur naast de dialyse-afdeling vermoed. Onder begeleiding 
van sfeervolle jazzklanken produceerde je posters van een kwaliteit 
waar we bij de nefrologie nog niet helemaal aan gewend waren. Ook 
zal ik ooit mijn voordeel doen met je adviezen voor het aanleggen van 
vijvers, al worden het er waarschijnlijk geen zeventien. 
De dialyseverpleegkundigen ben ik dankbaar voor hun hulp bij de 
uitvoering van de studies, ondanks het feit dat die soms 
interfereerden met de klinische gang van zaken en de onleesbaarheid 
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van mijn aantekeningen in de blauwe map vaak meer verwarring dan 
helderheid verschafte. 
Zeer veel dank ben ik verschuldigd aan de patiënten van de afdeling 
Hemodialyse van het Erasmus MC, van wie velen bij herhaling bereid 
waren hun medewerking te verlenen aan het onderzoek. 
De leden van de promotiecommissie, de hoogleraren Pols, Roelandt en 
Nubé, dank ik voor hun snelle beoordeling van het proefschrift. Ik 
dank ook Prof. Klein voor zijn bereidheid deel te nemen aan de 
oppositie.  
Professor Lindholm, thank you very much for coming all the way to 
the Netherlands. I hope the interest we share in the cardiac function 
in dialysis patients may lead to future joint research ventures. 
Mijn paranimfen, Robert Nette en Bart Han-Liong Ie:  
Beste Robert, jou proefschrift was het eerste product van de 
Hemodialysis Research Unit (HRU). Nu is het jouw beurt om 
“Hooggeleerde Opponens” in mijn oor te sissen.  
Bart Liong, weliswaar is dit boekje is geen afspiegeling van onze 
gezamenlijke interessen (op de voorplaat na misschien), maar de 
medische wereld is je niet onbekend. Aangezien promoveren wel 
“trouwen in je eentje” wordt genoemd, ben jij nu weer mijn getuige. 
Mijn moeder dank ik voor haar niet aflatende steun, liefde en warme 
belangstelling, met een heldere, nuchtere kijk op de dingen: Kun je 
me nu eens kort uitleggen wat je allemaal hebt onderzocht?! 
Mijn vader kwam helemaal met de boot uit Indonesië om de studie 
van zijn keuze te gaan doen. Ik hoefde slechts in zijn voetsporen te 
treden. Dit proefschrift is aan hem opgedragen. 
Ten slotte, mijn lieve Sheila, jouw passie voor wetenschappelijk 
onderzoek werkt aanstekelijk! Maar hier, in deze sprookjesachtige 
wereld van sneeuw, dromen we vooral van wat de lente ons hopelijk 
zal brengen. Hebban olla uogola nestas hagunnan…  
 
 
Heinola, januari 2005 
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